# generate_tests\Test mAB\Mix-all.txt
# Generated sample - 9568H|actoxumab|Homo sapiens||H-GAMMA-1 (VH (1-122) [D1] + CH1 (123-220) [D2] + CH2 (236-345) [D3] + CH3 (346-450) [D4])|||||||452|452|||MW undefined|MW undefined| - Trypsin - 50%
LSCAASGFSFSNYGMHWVR
NTLYLQMNSLR
GVIDVFDIWGQGTVVTVSSASTK
TPEVTCVVVDVSHEDPEVK
VVSVLTVLHQDWLNGK
GFYPSDIAVEWESNGQPENNYK
TTPPVLDSDGSFFLYSK
WQQGNVFSCSVMHEALHNHYTQK
# Generated sample - 9568H|actoxumab|Homo sapiens||H-GAMMA-1 (VH (1-122) [D1] + CH1 (123-220) [D2] + CH2 (236-345) [D3] + CH3 (346-450) [D4])|||||||452|452|||MW undefined|MW undefined| - Chymotrypsin - 50%
RAEDTAVY
APSSKSTSGGTAAL
GGPSVF
PPKPKDTL
ISRTPEVTCVVVDVSHEDPEVKF
VDGVEVHNAKTKPREEQY
PAPIEKTISKAKGQPREPQVY
PSDIAVEW
QQGNVF
# Generated sample - 9568H|actoxumab|Homo sapiens||H-GAMMA-1 (VH (1-122) [D1] + CH1 (123-220) [D2] + CH2 (236-345) [D3] + CH3 (346-450) [D4])|||||||452|452|||MW undefined|MW undefined| - LysC - 50%
GRFTISRDNSK
STSGGTAALGCLVK
THTCPPCPAPELLGGPSVFLFPPK
DTLMISRTPEVTCVVVDVSHEDPEVK
ALPAPIEK
GQPREPQVYTLPPSREEMTK
NQVSLTCLVK
SLSLSPGK
# Generated sample - 9568H|actoxumab|Homo sapiens||H-GAMMA-1 (VH (1-122) [D1] + CH1 (123-220) [D2] + CH2 (236-345) [D3] + CH3 (346-450) [D4])|||||||452|452|||MW undefined|MW undefined| - Aspecific - 50%
LVESGGGVVQPGRSLRLSCAASGFSFSNYGMHWVRQAP
ESGGGVVQPGRSLRLSCAASGFSFSNYG
VVQPGRSLRLSCA
QPGRSLRLSCAASGFSFSN
PGRSLRLSCAA
GRSLRLSCAASGFSFSNYGMHWVRQAPGKGLEWVAL
SLRLSCAASGFSFSNYGMHWVRQAPGKGLEWVAL
LSCAASGFSFSNYGMHWVRQAP
CAASGFSFSNYGMHWVRQAPGKGLEWVAL
AASGFSFSNYGMHW
YGMHWVRQAPGKGLEWVALIWYDGS
RQAPGKGLEWVALIWYDGSNEDYTDS
PGKGLEWVALIWY
WVALIWYDGSNEDYT
WVALIWYDGSNEDYTDSVKG
IWYDGSNEDYTDSVKGRFTISRDN
IWYDGSNEDYTDSVKGRFTISRDNSKNTLYL
WYDGSNEDYTDS
DGSNEDYTDSVKGRFTISRDNSKNTLYLQMNSLRAED
EDYTDSVKGRFTI
DYTDSVKGRFTISRDNSKNTL
YTDSVKG
TDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYC
DSVKGRFTISRDNSK
SVKGRFTISRDNSKNTLYLQMNSL
KGRFTISRDNSKNTLYLQMNS
RFTISRDNSKNTLYLQMNSLRAEDTAVY
TISRDNSKNTLYLQMNSL
TISRDNSKNTLYLQMNSLRAEDT
TISRDNSKNTLYLQMNSLRAEDTAVYYCARWGMVRG
SRDNSKNTLYLQMNSLRAEDTAVYYCARWGM
SKNTLYLQMNSLRA
KNTLYLQMNSLRAEDTAVYYCARWGMVRGVIDVFDIWG
TLYLQMNSLRAED
MNSLRAEDTAVYYCARW
RAEDTAVYYCARWGMVRGVIDVFDIWGQGT
DTAVYYCARWGM
YCARWGMVRGVIDVF
RWGMVRGVIDVFDIWGQGTVVT
IWGQGTVVTVSSASTKGPSVF
SSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPE
SASTKGPSVF
STKGPSVFPLAPS
TKGPSVFPLAPSSKSTSGGTAALGCLVKDYF
TKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPV
KGPSVFPLAPSSKSTSGGTAALG
SVFPLAPSSKSTSG
SVFPLAPSSKSTSGGTAALGCLV
PLAPSSKSTSGGTAALGCLVKDY
PLAPSSKSTSGGTAALGCLVKDYFPEPVTV
APSSKSTSGGTAALGCLVKDY
SSKSTSGGTAALG
KSTSGGTAALGCLVKDYFPEPVTVSWNSG
STSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFP
ALGCLVKDYFPEPVTVSWNS
ALGCLVKDYFPEPVTVSWNSGALTSGVHTF
LVKDYFP
VKDYFPEPVTVS
PEPVTVSWNSG
PVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSS
SWNSGALTSGVHTFPAVLQS
SGALTSGVHTFPAVLQSSG
SGALTSGVHTFPAVLQSSGLYSLSSVVTVP
SGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSS
GALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYIC
ALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTY
TSGVHTFPAVLQSSGL
GVHTFPAVLQSSGLYSLSSVVTVPSSSLG
TFPAVLQSSGLYSL
SSGLYSLSS
SGLYSLSSVVTVPSSSLGTQTYICNVN
GLYSLSSVVTVP
GLYSLSSVVTVPSSSLGTQTYICNVN
SLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVE
VVTVPSSSLGTQTYIC
VTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCDKTHT
VPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCDKTHTCP
PSSSLGTQ
SLGTQTYICNVNH
LGTQTYICNVNHKPSNTKVDKRVEPKSCDKT
GTQTYICNVNHKPSNTKVDKRVEPKSCDKTHTCPPC
YICNVNHKPSNTK
KPSNTKVDKRVEPKSCDKTHTCPPCPAP
NTKVDKRVEPKSCDKTHTCPPCPAPELLGGPSVFLF
VDKRVEPKSCDKTHTCPPCPAPELLGGPSVFLFP
EPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTL
PKSCDKTHTCPPCPAPELL
CDKTHTCPPCPAPEL
DKTHTCPPCPAPELLGGPSVFLFPP
KTHTCPPCPAPE
THTCPPCPAPE
THTCPPCPAPEL
HTCPPCPA
PPCPAPELLGGPSVFLFPPKPKDTLMISRT
PCPAPELLGGPSVF
PCPAPELLGGPSVFLFPPKPKDTL
GPSVFLFPPKPK
GPSVFLFPPKPKDTLMISRT
VFLFPPKPKDTLMISRTPEVTCVVVDVSHE
PKPKDTLMISRTPEVTCVVVDVSHED
DTLMISRTPE
DTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVH
TLMISRTPEVTCVVVDV
PEVTCVV
CVVVDVSHEDPEVKFNWYVDGVEVHN
VVVDVSHEDPEV
VVDVSHEDPEVKFNWYVDGVEVHNAKTKPRE
DVSHEDPEVKFNWYVDGVEVHNAKTKPREE
SHEDPEVKFNWYVDGVEVHNAKTKPREE
SHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVS
KFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDW
EVHNAKTKPREEQYNSTYRVVSVLTVLHQDWL
KTKPREE
TKPREEQYNSTYRVVSVLTVLHQD
QYNSTYRVVSVL
YNSTYRV
YNSTYRVVSVLTVL
NSTYRVVSVLTVLHQDWLNGKEYKCKVSNKA
RVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAK
LTVLHQDWLNGKEYKC
LTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQP
HQDWLNGKEYKCKVSNKALPAPI
LNGKEYKCKVS
NGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLP
KEYKCKVSNKALPAPIEKTISKAKGQPREPQVYT
KCKVSNKALPAPIEKT
VSNKALPAPIEKTISKAKGQPREPQ
NKALPAPIEKTISKAKGQPREPQVYT
LPAPIEKTISKAKGQPREPQVYTLPPSREEM
EKTISKAKGQPREPQVYTL
KTISKAKGQPREPQVYTLPP
SKAKGQPREPQVYTLP
SKAKGQPREPQVYTLPPSREEMTKNQVSL
KAKGQPREPQVYTLPPSR
GQPREPQVYTLPPSREEMTKNQV
EPQVYTLPPSREEMTKNQVSLTCLVKGF
QVYTLPPSRE
QVYTLPPSREEMTKNQVSLTCLVKGFY
YTLPPSRE
PSREEMT
PSREEMTKNQVSLTCLVKGFYPSDIAVEW
EEMTKNQV
QVSLTCLVKGFYPSDIAVEWESNGQPEN
VSLTCLVKGFYPSDI
LTCLVKGFYPSDIAVEWESNGQPENNYKTTPPV
YPSDIAVEWES
DIAVEWE
AVEWESNGQPENNYKTTPP
SNGQPENNYKTT
QPENNYKTTPPVLDSDGSFFLYSKLTVD
ENNYKTTPPVLDSDG
ENNYKTTPPVLDSDGSFFLYSKLTVDK
NNYKTTPPVLDSDG
NYKTTPPVLDSDGS
SFFLYSKLTVDKSRWQQGNVFSCSVMHEAL
SKLTVDKSRWQQGNVFSC
KLTVDKSRWQQGNVFSCSVM
LTVDKSRWQQGNVFSCSVMHEALHN
YTQKSLSLSP
# Generated sample - 9568H|actoxumab|Homo sapiens||H-GAMMA-1 (VH (1-122) [D1] + CH1 (123-220) [D2] + CH2 (236-345) [D3] + CH3 (346-450) [D4])|||||||452|452|||MW undefined|MW undefined| - Alfalytic protease - 50%
NYGMHWV
PGKGLEWV
LIWYDGS
FDIWGQGT
KDYFPEPV
CPPCPA
PELLGGPS
KFNWYV
LHQDWLNGKEYKCKV
KGFYPS
# Generated sample - 9568L|actoxumab|Homo sapiens||L-KAPPA (V-KAPPA (1-107) [D1] + C-KAPPA (108-214) [D2])|||||||214|214|||MW undefined|MW undefined| - Trypsin - 50%
DIQMTQSPSSVSASVGDR
ASQGISSWLAWYQHKPGK
LLIYAASSLQSGVPSR
SGTASVVCLLNNFYPR
DSTYSLSSTLTLSK
# Generated sample - 9568L|actoxumab|Homo sapiens||L-KAPPA (V-KAPPA (1-107) [D1] + C-KAPPA (108-214) [D2])|||||||214|214|||MW undefined|MW undefined| - Chymotrypsin - 50%
TQSPSSVSASVGDRVTITCRASQGISSW
QHKPGKAPKL
SGSGSGTDF
CQQANSF
GQGTKVEIKRTVAAPSVF
PPSDEQL
KVDNAL
# Generated sample - 9568L|actoxumab|Homo sapiens||L-KAPPA (V-KAPPA (1-107) [D1] + C-KAPPA (108-214) [D2])|||||||214|214|||MW undefined|MW undefined| - LysC - 50%
RTVAAPSVFIFPPSDEQLK
SGTASVVCLLNNFYPREAK
# Generated sample - 9568L|actoxumab|Homo sapiens||L-KAPPA (V-KAPPA (1-107) [D1] + C-KAPPA (108-214) [D2])|||||||214|214|||MW undefined|MW undefined| - Aspecific - 50%
DIQMTQSPS
PSSVSASVGDRVTITCRASQGISSWLAWYQHKPGKAP
SASVGDRVTITCRASQGISSWLAWYQHKPGKAPKL
GDRVTITCRASQGISSWLA
DRVTITCRASQGISSWLAWYQHKPGKAPKLLI
RVTITCRASQGISSWLAWYQHKPGKAPK
TCRASQGISSW
TCRASQGISSWLAWYQHKP
CRASQGISSWLAWYQHKPGKA
SQGISSWLAWYQHKPGKAPKLL
GISSWLAWYQHKPGKAPKLLI
QHKPGKAPKLLIYAAS
QHKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTI
GKAPKLLIYAASSLQSGVPSRFSGSGSGTD
GKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLT
APKLLIYAASSLQS
APKLLIYAASSLQSGVPSR
GVPSRFSG
PSRFSGSGSGT
FTLTISSLQPEDFATYYCQQANS
FTLTISSLQPEDFATYYCQQANSFPWTFGQGTKV
TISSLQPEDFATYYCQQANSFPWTFGQGTKVEIK
SSLQPEDFATYYCQQANSFP
FATYYCQQANSFPWTFGQGTKVEIKR
YYCQQANSFPWTFGQGTKVEI
CQQANSFPWTFGQGTKVEIKRTVAAPSVF
QQANSFPWTFGQGTKVEIKRTVAAPSVFIFP
ANSFPWTFGQGTKVEIKRTVAAPSVFIFPPSDEQ
FPWTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVV
QGTKVEIKRTVAAPSVFIFPPSD
GTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVV
TKVEIKRTVAAP
EIKRTVAA
AAPSVFIFPPSDEQLKSGTASVVCLLNNFY
VFIFPPS
IFPPSDEQLKSGTASVVCLLNNFY
IFPPSDEQLKSGTASVVCLLNNFYPREAKV
PPSDEQLKSGTASVVCLLNNFYPR
SDEQLKSG
SDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGN
EQLKSGTASVV
EQLKSGTASVVCLLN
TASVVCLLNNFYP
SVVCLLNNFYPREAKVQWKVDNALQSGN
CLLNNFYPREAKVQWKVDNAL
NNFYPREAKVQWKVDNALQSGNSQESVT
NNFYPREAKVQWKVDNALQSGNSQESVTE
NNFYPREAKVQWKVDNALQSGNSQESVTEQDSK
PREAKVQWKVDNALQSGNSQ
PREAKVQWKVDNALQSGNSQES
PREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSST
REAKVQWKVDNALQ
KVQWKVDNALQ
WKVDNALQSGNSQESVTEQDSKDSTYS
VDNALQSGNSQESVTEQDSKDSTYSLSS
DNALQSGNSQESVTEQDSKDSTYSLSSTLTL
NSQESVTEQDSKDSTYSLSSTLTLSKADYEKHK
NSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYA
ESVTEQDSKDSTYSLSSTLTLSK
ESVTEQDSKDSTYSLSSTLTLSKADYEKH
VTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQ
QDSKDSTYSLSSTLTLSKADYEKHKVYACEVTH
QDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLS
DSKDSTYSLSSTLTLSKADY
SKDSTYSLSSTLTLSKADYE
YSLSSTLTLSKAD
TLTLSKA
LTLSKAD
LSKADYEKHKVYACEVTHQGLSSPVTKSF
ADYEKHKVYACEVTHQGLSSPV
ADYEKHKVYACEVTHQGLSSPVTKSFNRGEC
KHKVYACEV
YACEVTH
# Generated sample - 9568L|actoxumab|Homo sapiens||L-KAPPA (V-KAPPA (1-107) [D1] + C-KAPPA (108-214) [D2])|||||||214|214|||MW undefined|MW undefined| - Alfalytic protease - 50%
PKLLIYA
LQPEDFA
FIFPPS
CLLNNFYPREA
DYEKHKV
# Generated sample - 9953H|adalimumab beta|Homo sapiens||H-GAMMA-1 (VH (1-121) [D1] + CH1 (122-219) [D2] + CH2 (235-344) [D3] + CH3 (345-449) [D4])|||||||451|451|||MW undefined|MW undefined| - Trypsin - 50%
EVQLVESGGGLVQPGR
NSLYLQMNSLR
AEDTAVYYCAK
TPEVTCVVVDVSHEDPEVK
VVSVLTVLHQDWLNGK
ALPAPIEK
EPQVYTLPPSR
NQVSLTCLVK
TTPPVLDSDGSFFLYSK
WQQGNVFSCSVMHEALHNHYTQK
SLSLSPGK
# Generated sample - 9953H|adalimumab beta|Homo sapiens||H-GAMMA-1 (VH (1-121) [D1] + CH1 (122-219) [D2] + CH2 (235-344) [D3] + CH3 (345-449) [D4])|||||||451|451|||MW undefined|MW undefined| - Chymotrypsin - 50%
SCAASGF
VSAITW
ADSVEGRF
STASSL
PEPVTVSW
TSGVHTF
SSVVTVPSSSL
GGPSVF
PPKPKDTL
KCKVSNKAL
PAPIEKTISKAKGQPREPQVY
TKNQVSL
PSDIAVEW
ESNGQPENNY
# Generated sample - 9953H|adalimumab beta|Homo sapiens||H-GAMMA-1 (VH (1-121) [D1] + CH1 (122-219) [D2] + CH2 (235-344) [D3] + CH3 (345-449) [D4])|||||||451|451|||MW undefined|MW undefined| - LysC - 50%
NSLYLQMNSLRAEDTAVYYCAK
VSYLSTASSLDYWGQGTLVTVSSASTK
GPSVFPLAPSSK
STSGGTAALGCLVK
ALPAPIEK
GFYPSDIAVEWESNGQPENNYK
SRWQQGNVFSCSVMHEALHNHYTQK
# Generated sample - 9953H|adalimumab beta|Homo sapiens||H-GAMMA-1 (VH (1-121) [D1] + CH1 (122-219) [D2] + CH2 (235-344) [D3] + CH3 (345-449) [D4])|||||||451|451|||MW undefined|MW undefined| - Aspecific - 50%
EVQLVESGGGLVQPGRSL
VQLVESGGGLVQPGRSLRLSCAASGFTFDD
SGGGLVQP
GGGLVQPGRSLRLSC
VQPGRSLRLSCAASGFTFDDYAMHWVRQAPGKGLEWVSAI
GRSLRLSCAASGFTFDDYAMHW
LSCAASGFTFDDYAMHWVRQAPGKGLEWVSAITWNSGH
SCAASGFTFDDYAMHW
GFTFDDYAMHWVRQAPGKGLEWVSAITWNSGHIDYA
FTFDDYAMHWVRQAPGKG
FTFDDYAMHWVRQAPGKGLEWVSAITWNS
FDDYAMHWVRQAPGKGLEWVSAITWNSGHI
DDYAMHWVRQAPGKG
DYAMHWVRQAPGKGLEWVSAITWNSGHIDYADS
HWVRQAPGKGLEW
WVRQAPGKGLEWVSAITWNSGHID
VRQAPGKGLEWVSAITWNSGHI
APGKGLEWVSAITWNSGHI
EWVSAITWNSGHIDYADS
VSAITWNSGHIDYADSVEGRFTISRDNAKNSLYL
ITWNSGHIDYADSVEGRFTISRDNAKNSLYLQMNSLRAED
DYADSVEGRFTISRDNAKNSLYLQMNSL
ADSVEGRFTISRDNAKN
DSVEGRFTISRDNAKNSLYLQMNSLRAEDT
DNAKNSLYLQMNSLRAEDT
SLYLQMNS
SLYLQMNSLRAEDTAVYYCAKVSYLSTASSLDYWG
YLQMNSLRAED
LQMNSLRAEDTAVYYCAKVSYLSTASSLDYWGQG
SLRAEDTA
YYCAKVSYLSTASSLDYWGQG
LSTASSLDYWGQGTLVTVSSASTKGPSVFPLAPSS
SLDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAAL
GQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCL
SSASTKGPSVFPLAPSSKSTSGGTAALGCLV
ASTKGPSVFP
PSVFPLAPSSKSTS
FPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGAL
SSKSTSGGTAALGCLVKDYFPEPVTVSWNSGA
KSTSGGTAALG
TAALGCLVKDYFPEPVTVSWNSG
LGCLVKDYFPEPVTVSWNSGALTSGVHTF
GCLVKDYFPEPVTVSWNSGALTSGVH
PEPVTVSWNSGALTSGVHTFP
SWNSGALTSGVHTF
NSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQ
SGALTSGVHTFPAVLQSSGLY
TSGVHTFPA
GVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYI
FPAVLQSSGLYSLSSVV
QSSGLYSLSSVVTVPSSSLGTQTYICNVNHK
GLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVD
LYSLSSVVTVPSSSLGTQTYI
YSLSSVVTVPSSSLGTQT
YSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVE
SLSSVVTVPSSSLGTQTYICNVN
SLSSVVTVPSSSLGTQTYICNVNHK
LSSVVTVPSSSLGTQTYICNVNHKPSNTKV
VVTVPSSSLGTQTYICNVNHKPSNTKVDKK
SLGTQTYIC
QTYICNVNHKPSNTKVDKKVEPKSCDKTH
CNVNHKPSNTKVDKKVEP
NVNHKPSNTKV
KPSNTKVDKKVEPKS
KPSNTKVDKKVEPKSCDKTHTCPPCPA
PSNTKVDKKVE
PSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFP
KVDKKVEPKS
DKKVEPKSCD
DKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMIS
THTCPPCPAPELLGGPSVFLFPPKPKDTLM
PPCPAPELLGGPSVFLFPPKPKDTLMIS
LLGGPSVFLFPPKPKDTL
LLGGPSVFLFPPKPKDTLMIS
VFLFPPKPKDTL
LFPPKPKDTLMISRTP
LFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNW
FPPKPKDTLMISRTPEVTCVVVDVSHEDPEV
PPKPKDT
PKPKDTLMISRT
KPKDTLMISRTPEV
KPKDTLMISRTPEVTCV
DTLMISRTPEVTCVVVDVSHEDPEVKFNWY
TLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGV
RTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKP
EVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQY
TCVVVDVSHEDPEVKFNWYV
TCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNST
CVVVDVSHEDPE
CVVVDVSHEDPEVKFNWYVDGVE
VVVDVSHEDPEVKFNWYV
VVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNST
VSHEDPEV
EDPEVKFNWYVDGVEVHNAKTKPRE
EVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVL
EVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLH
VKFNWYVDGVEVHNAKTK
WYVDGVEVHNAKT
HNAKTKPREEQYNST
NAKTKPREEQYNST
KTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSN
TKPREEQYNSTYRVV
KPREEQYNSTYRVVSVLTVLHQ
PREEQYNSTYRVVSVLTVLHQDWLNGKEY
REEQYNSTYRVVSVLTVLHQDWLNG
EEQYNST
QYNSTYRVVSV
NSTYRVVS
LTVLHQDWLNGKEYK
VLHQDWLNGKEYK
LHQDWLNGK
DWLNGKEYKCKVSNKALPAPIEK
LNGKEYKCKVSNKA
KALPAPIEKTISKAKGQPRE
KALPAPIEKTISKAKGQPREPQVYTLPPSRDELTKNQVS
ALPAPIEKTISKAKGQPREPQVYTLPPSRDELTKNQVS
APIEKTISKAKGQPREPQVYTLPPSRDELTKNQVSLTCLV
TISKAKGQPREPQVYTLPPSRDELTKNQVSLTCLVKGFY
KAKGQPREPQVY
KAKGQPREPQVYTLPPS
KGQPREPQVYTLPPSRDELTKNQVSL
QVYTLPPSRDELTKNQVSLTCLVKGFYPSDI
LPPSRDELTKNQVSLTC
PSRDELTKNQVSLTCLVKGFYP
SRDELTKNQVSL
RDELTKNQVSLTCLVKGFYPSDIAVEWESNGQPENN
LTKNQVS
LTKNQVSLT
TKNQVSLTC
KNQVSLTCLVK
QVSLTCLVKGFYPSDIAVEWESN
CLVKGFYPSDIAVEWESNGQPENNYKTT
LVKGFYPSDIAVEW
DIAVEWESNGQPENNYKTTPPVL
DIAVEWESNGQPENNYKTTPPVLDSDGSFFL
IAVEWESNGQPENNYKTTPPV
EWESNGQPENNYKTTPPVLDSDGSFFLYSKL
ESNGQPENNYKTTPPVLDSD
ESNGQPENNYKTTPPVLDSDGSFFLY
NGQPENNYKTTPPVLDSDGSFFLY
NGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSR
QPENNYKTTPPVLDSDGSFFLY
TTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEA
TPPVLDSDGSFFLY
DGSFFLYSKLTVDKSRW
DGSFFLYSKLTVDKSRWQQGNVFSCSV
SFFLYSKLTVDKSRWQQGNVFSC
VDKSRWQQ
DKSRWQQGNVFSCS
RWQQGNVFSCSVMH
RWQQGNVFSCSVMHEALHNHYTQKSLSLS
GNVFSCSVMHEALHNHY
SCSVMHEALHNHYTQKSL
ALHNHYTQKSLSLS
HYTQKSLSL
# Generated sample - 9953H|adalimumab beta|Homo sapiens||H-GAMMA-1 (VH (1-121) [D1] + CH1 (122-219) [D2] + CH2 (235-344) [D3] + CH3 (345-449) [D4])|||||||451|451|||MW undefined|MW undefined| - Alfalytic protease - 50%
PELLGGPS
HEDPEV
KGQPREPQV
KGFYPS
LHNHYT
# Generated sample - 9953L|adalimumab beta|Homo sapiens||L-KAPPA (V-KAPPA (1-107) [D1] + C-KAPPA (108-214) [D2])|||||||214|214|||MW undefined|MW undefined| - Trypsin - 50%
VTITCR
ASQGIR
NYLAWYQQKPGK
LLIYAASTLQSGVPSR
SGTASVVCLLNNFYPR
# Generated sample - 9953L|adalimumab beta|Homo sapiens||L-KAPPA (V-KAPPA (1-107) [D1] + C-KAPPA (108-214) [D2])|||||||214|214|||MW undefined|MW undefined| - Chymotrypsin - 50%
TQSPSSL
SGSGSGTDF
QPEDVATY
GQGTKVEIKRTVAAPSVF
KSGTASVVCL
PREAKVQW
KVDNAL
EKHKVY
SSPVTKSF
# Generated sample - 9953L|adalimumab beta|Homo sapiens||L-KAPPA (V-KAPPA (1-107) [D1] + C-KAPPA (108-214) [D2])|||||||214|214|||MW undefined|MW undefined| - LysC - 50%
SGTASVVCLLNNFYPREAK
VDNALQSGNSQESVTEQDSK
DSTYSLSSTLTLSK
SFNRGEC
# Generated sample - 9953L|adalimumab beta|Homo sapiens||L-KAPPA (V-KAPPA (1-107) [D1] + C-KAPPA (108-214) [D2])|||||||214|214|||MW undefined|MW undefined| - Aspecific - 50%
MTQSPSSLSASVG
PSSLSASVGDRVTI
LSASVGDRVTITCRASQGIRN
DRVTITCRASQGIRNYLAWYQQKPGKAPKLLIY
TITCRASQGIRNYLAWYQQKPGKAPKLLIYAASTLQSGVP
ITCRASQGIRNYLAWYQQKPGKAPKLLI
TCRASQGIRNYLAWYQQKPGKAPKLLIYAASTLQSGVP
RASQGIRNYLAWYQQ
RASQGIRNYLAWYQQKPGKAPKLLIYAASTLQS
LAWYQQKPGKAPK
GKAPKLLIYAASTLQSGVPSRF
KAPKLLIY
LIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDV
IYAASTLQSGVPSRFSGSGSGTDFTLTISSL
YAASTLQSGVPSRFSGSGSGTDFTLTISSLQPE
STLQSGVPSRFSGSGSGTDFTLTISSLQPEDVA
LQSGVPSRFSGSGSGTDFTLT
QSGVPSRFSGSGSG
QSGVPSRFSGSGSGTDFTLTISSLQPEDVA
SGVPSRFSGSGSGTDFTLTISSLQPEDVA
VPSRFSGSGSGT
SGSGSGTDFTLTISSLQPEDVATYYCQRYNRAPYTFGQG
SGSGTDFTLTISSLQPE
SGTDFTLTISSLQPEDVAT
TLTISSLQPEDVATYYCQRYNRAPYTF
QPEDVATYYCQRYNRAPYTFGQGTKVEIKRTVAAPSV
PEDVATYYCQRYNRAPYTFGQGTKV
VATYYCQ
VATYYCQRYNRAPYTFGQG
YCQRYNRAPYTFGQGTKVEIKRTVAAP
YCQRYNRAPYTFGQGTKVEIKRTVAAPSVFIFPPSDEQ
CQRYNRAPYTFGQGTKVEIKRTVAAPSVFIFPP
APYTFGQGTKVEIKRTVAAP
PYTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVV
YTFGQGTKVEI
FGQGTKVEIKRTVAAPSVFIFPPSDE
GQGTKVEIKRTVAAPSVFIFPPSDEQL
QGTKVEIKRTVAAPSVFIF
KVEIKRTVAAPSVFIFPPSDEQ
EIKRTVAA
IKRTVAAPSVFIFPPSDEQLKSGTASVVCL
IKRTVAAPSVFIFPPSDEQLKSGTASVVCLL
TVAAPSVFIFPPSDEQLKSGTASVVC
VAAPSVF
AAPSVFIFPPSDEQLKSGTASVVCLLNN
APSVFIFPPSDE
VFIFPPSDEQLKSGTASVVCLLNNF
FPPSDEQLKSGTASVVCL
EQLKSGTASVVCLLNN
QLKSGTASVVCLLNNFYPR
TASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDS
VCLLNNFYPREAKVQWKVDNALQSGN
FYPREAKVQWKVDNALQS
YPREAKVQWKVDNALQSGN
YPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTL
REAKVQWKVDNALQSG
AKVQWKVDNALQSGNSQESVTEQ
AKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSST
VQWKVDNA
QWKVDNA
WKVDNALQSGNSQESVTEQDSKDST
WKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYE
QSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYA
GNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACE
SQESVTEQDSKDSTYSLSST
QESVTEQDSKDSTYSLSSTLTLSKADYEKH
QESVTEQDSKDSTYSLSSTLTLSKADYEKHKV
ESVTEQDSKDSTYSLSSTLTL
SKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVT
TYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFN
SSTLTLSKADYEKHKVYAC
LTLSKADYEKH
ADYEKHKVYACEVTHQGLSSPVTKSF
DYEKHKVYACEVTHQGLSSP
EKHKVYACEVT
KHKVYACEVTHQGLSSPVTKSFNRGEC
ACEVTHQGLSSPVTKSFNR
EVTHQGLSSPVTKSFNRGE
SPVTKSFNRGEC
# Generated sample - 9953L|adalimumab beta|Homo sapiens||L-KAPPA (V-KAPPA (1-107) [D1] + C-KAPPA (108-214) [D2])|||||||214|214|||MW undefined|MW undefined| - Alfalytic protease - 50%
QGIRNYLA
PKLLIYA
LQPEDV
YYCQRYNRA
CLLNNFYPREA
DYEKHKV
FNRGEC
# Generated sample - 10881H|abelacimab|Homo sapiens||H-GAMMA-1 (VH (1-122) [D1] + CH1 (123-220) [D2] + CH2 (236-345) [D3] + CH3 (346-450) [D4])|||||||452|452|||MW undefined|MW undefined| - Trypsin - 50%
QVQLLESGGGLVQPGGSLR
LSCAASGFTFSTAAMSWVR
AEDTAVYYCAR
FNWYVDGVEVHNAK
VVSVLTVLHQDWLNGK
EPQVYTLPPSR
GFYPSDIAVEWESNGQPENNYK
TTPPVLDSDGSFFLYSK
SLSLSPGK
# Generated sample - 10881H|abelacimab|Homo sapiens||H-GAMMA-1 (VH (1-122) [D1] + CH1 (123-220) [D2] + CH2 (236-345) [D3] + CH3 (346-450) [D4])|||||||452|452|||MW undefined|MW undefined| - Chymotrypsin - 50%
ESGGGL
VQPGGSL
TISRDNSKNTL
RAEDTAVY
VTVSSASTKGPSVF
PEPVTVSW
TSGVHTF
GGPSVF
KCKVSNKAL
TKNQVSL
PSDIAVEW
KTTPPVL
DSDGSF
# Generated sample - 10881H|abelacimab|Homo sapiens||H-GAMMA-1 (VH (1-122) [D1] + CH1 (123-220) [D2] + CH2 (236-345) [D3] + CH3 (346-450) [D4])|||||||452|452|||MW undefined|MW undefined| - LysC - 50%
GRFTISRDNSK
GPSVFPLAPSSK
THTCPPCPAPELLGGPSVFLFPPK
DTLMISRTPEVTCVVVAVSHEDPEVK
FNWYVDGVEVHNAK
PREEQYNSTYRVVSVLTVLHQDWLNGK
GQPREPQVYTLPPSREEMTK
NQVSLTCLVK
GFYPSDIAVEWESNGQPENNYK
SRWQQGNVFSCSVMHEALHNHYTQK
SLSLSPGK
# Generated sample - 10881H|abelacimab|Homo sapiens||H-GAMMA-1 (VH (1-122) [D1] + CH1 (123-220) [D2] + CH2 (236-345) [D3] + CH3 (346-450) [D4])|||||||452|452|||MW undefined|MW undefined| - Aspecific - 50%
VQLLESGGGLVQPGG
VQLLESGGGLVQPGGSLRLSCAASGFTFSTAAMSWVRQAP
GGGLVQPGGSL
GGGLVQPGGSLRLSCAASGFTFSTA
GLVQPGG
PGGSLRLSCAASGFTFSTAAMSWV
PGGSLRLSCAASGFTFSTAAMSWVRQAPGKGLEWVS
LRLSCAASGFTFSTAAMSWVRQAPGKGLEWVSGIS
RLSCAASGFTFSTAAMSWVR
GFTFSTA
FTFSTAAMSWVRQ
FSTAAMSWVRQAPGKGLEWVSGISGSGSSTYYADSV
TAAMSWVRQAPGK
AAMSWVRQA
SWVRQAPGKGLEWVSGISGSGSSTYYADSVKGRFTI
VRQAPGKGLEWVSGISGSGSSTYYADSVKG
RQAPGKGLEWVS
APGKGLEWVSGISGSGSSTYYA
WVSGISGS
GISGSGSSTYYADSVKGRFTIS
GISGSGSSTYYADSVKGRFTISRDNSKN
ADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAR
RFTISRDNSKNTLYLQMNSLR
SRDNSKNTLYLQMN
NTLYLQMNSLRA
TLYLQMNSLRAEDTAVYYC
TLYLQMNSLRAEDTAVYYCAR
LRAEDTAVYY
RAEDTAVYYCARELSYLYSGYYFDYWGQGTLVTVSS
EDTAVYYCARELSYLYSGYYFDYWGQGTLVTVSSAST
DTAVYYCARELSYLYSGYYFDYWG
TAVYYCARELSYLYSGYYFDYWGQ
AVYYCARELSYL
RELSYLYSGYYFDYW
RELSYLYSGYYFDYWGQGTL
RELSYLYSGYYFDYWGQGTLVTVS
LSYLYSGYYF
LSYLYSGYYFDYWG
LSYLYSGYYFDYWGQGTLVTVSSASTKGPSVFPLA
WGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTA
GQGTLVTVSSASTKGPSVFPLAPS
GQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTA
QGTLVTV
GTLVTVSSASTKGPSVFPLAPSSKSTSGGT
VSSASTKGPSVFPLAPSSKSTSGGT
KGPSVFPLAPSSKSTSGGTAALGCL
SKSTSGGTAAL
GGTAALGCLVKDYFPEPVTVSWNS
VKDYFPEPVTVSWNSGALTSGVHTF
KDYFPEPVTVSWNSGALT
DYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSS
EPVTVSWNSGALTSGVHTFPAVLQ
VSWNSGALTSGVHTFPAVLQSS
VSWNSGALTSGVHTFPAVLQSSGL
SGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTY
LTSGVHTFPAVL
SGVHTFPAVLQSSGLYSLSS
SGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICN
GVHTFPAVLQSSGLYSLSSVVTV
VHTFPAVLQSSGLYSLSS
TFPAVLQSSGLYSLSSVV
GLYSLSSVVTVPSSSLGTQTYICNV
GLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVD
SLSSVVTVPSSS
SLSSVVTVPSSSLGTQTYICNVN
SVVTVPSSS
LGTQTYICNVNHKPSNTKVDKRVEPKSC
YICNVNH
YICNVNHKPSNTKVDK
KPSNTKVDKRVEPKSCDKTHTCPPCPA
VDKRVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPK
VEPKSCDKTHTCPPCPAPEL
EPKSCDKTHTCPPCPAPELLGGPSVFLFPPKP
KSCDKTHTCPPCPA
DKTHTCPPCPAPELLGGPSVF
KTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVT
PAPELLGGPSVFLFPPKPKDTLMISRTPE
APELLGGP
LLGGPSVFLFPPKPKDTLMI
PKDTLMISRTPEVTCVVVAVSHEDPEV
KDTLMISRTPEVTCVVVAVS
LMISRTPEVTCVVVAVSHEDPEV
ISRTPEVTCVVVAVSHEDPEVKFN
TCVVVAVSHEDPEVKFNWYVDGVEVHNAKTKPREEQY
CVVVAVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTY
VAVSHEDPEV
AVSHEDPE
AVSHEDPEVKFNWYVDGV
HEDPEVKFNWYVDGVEVHNAKTKPREEQYNS
EDPEVKFNWYV
DPEVKFNWYV
PEVKFNWYVDGVEVHNA
PEVKFNWYVDGVEVHNAKTK
VKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVL
FNWYVDG
NWYVDGVEVHNAKTKPREEQYNS
YVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGK
EVHNAKTKPREEQYNSTYRVVSVL
EVHNAKTKPREEQYNSTYRVVSVLTVLH
HNAKTKP
HNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVS
REEQYNSTYR
REEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNK
YNSTYRV
YNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALAAPIE
NSTYRVVSVLTVLHQDWL
NSTYRVVSVLTVLHQDWLNGKEYKCK
NSTYRVVSVLTVLHQDWLNGKEYKCKVSNK
RVVSVLTVLHQ
VLTVLHQDWL
TVLHQDWLNGKEYKCKVSNKALAAPI
VLHQDWLNGKEYKCKVSNKALAA
LHQDWLNGKEYKCKVSN
HQDWLNGKEYKCKVSNKAL
QDWLNGKEYKCKVSNKALAAPIEKTISKAKGQP
DWLNGKEYKCKVSNKALAAPIEKTISKAKGQPREPQV
NGKEYKCKVSNKALAAPIEKTI
GKEYKCKVSNKALAAPIEKTISKAKGQPREPQV
YKCKVSNKALAAPIEKTISKAKGQPREPQVYTLPP
NKALAAPIEKTISKAKGQPREPQVY
APIEKTISK
EPQVYTLPPSREEMTKNQ
YTLPPSREEMTKNQVSL
REEMTKNQVSLTCLVKGFYPSDIAVEWESNG
EMTKNQVSLTCLVKGFYPSDIAVEWESN
MTKNQVSL
TKNQVSLTCLVKG
QVSLTCL
QVSLTCLVKGFYPSDIAVEWESNG
CLVKGFYPSDIAVEWESNG
CLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFL
LVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLY
GFYPSDIAVE
GFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSF
FYPSDIA
DIAVEWESNGQPENNYKTTPPVLDSDGSFF
AVEWESNGQPE
ESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKS
NGQPENNYKTTPPVLDSDGSFFLYSK
GQPENNYKTT
GQPENNYKTTPPVL
PPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVM
VLDSDGS
LYSKLTVDKSRWQQGNVFSCSVMHEA
TVDKSRWQQGNVFS
KSRWQQGNVFSCSVMHEALH
WQQGNVFSCS
MHEALHNHYTQKSL
# Generated sample - 10881H|abelacimab|Homo sapiens||H-GAMMA-1 (VH (1-122) [D1] + CH1 (123-220) [D2] + CH2 (236-345) [D3] + CH3 (346-450) [D4])|||||||452|452|||MW undefined|MW undefined| - Alfalytic protease - 50%
PGKGLEWV
GYYFDYWGQGT
CPPCPA
PELLGGPS
FLFPPKPKDT
HEDPEV
KGFYPS
NGQPENNYKT
RWQQGNV
LHNHYT
# Generated sample - 10881L|abelacimab|Homo sapiens||L-LAMBDA (V-LAMBDA (1-110) [D1] + C-LAMBDA (111-216) [D2])|||||||216|216|||MW undefined|MW undefined| - Trypsin - 50%
NYNRPSGVPDR
SGTSASLAISGLQSEDEADYYCSAWDQR
QFDVVFGGGTK
LTVLGQPK
AAPSVTLFPPSSEELQANK
ADSSPVK
AGVETTTPSK
# Generated sample - 10881L|abelacimab|Homo sapiens||L-LAMBDA (V-LAMBDA (1-110) [D1] + C-LAMBDA (111-216) [D2])|||||||216|216|||MW undefined|MW undefined| - Chymotrypsin - 50%
PGTAPKL
SGSKSGTSASL
QSEDEADY
GQPKAAPSVTL
# Generated sample - 10881L|abelacimab|Homo sapiens||L-LAMBDA (V-LAMBDA (1-110) [D1] + C-LAMBDA (111-216) [D2])|||||||216|216|||MW undefined|MW undefined| - LysC - 50%
SGTSASLAISGLQSEDEADYYCSAWDQRQFDVVFGGGTK
AAPSVTLFPPSSEELQANK
ATLVCLISDFYPGAVTVAWK
YAASSYLSLTPEQWK
SHRSYSCQVTHEGSTVEK
# Generated sample - 10881L|abelacimab|Homo sapiens||L-LAMBDA (V-LAMBDA (1-110) [D1] + C-LAMBDA (111-216) [D2])|||||||216|216|||MW undefined|MW undefined| - Aspecific - 50%
SVLTQPPSASGTPGQRVTISCSG
LTQPPSASGTPGQ
QPPSASGTPGQRVTISCSGSSSNIGS
QPPSASGTPGQRVTISCSGSSSNIGSNDVSWYQQLPGTAP
PSASGTPGQRVTISCSGSSSNIGSNDVSWYQ
SASGTPGQRVTISCSGSSSNIGSNDVSWYQQLP
TPGQRVTISCSGSSSNIGS
QRVTISCSGSSS
QRVTISCSGSSSNIGSNDVSWYQQLPGTAPKL
GSSSNIGSNDVSW
SSSNIGSNDVSWYQQL
IGSNDVSW
VSWYQQLPGTAPKLLIYKNYNRPSGVPDRFSG
QQLPGTAPKLLIYKNYNRPSGVPDRFSGS
TAPKLLIYKNYNRPSGVPDRFSGSKSGTSASLAI
APKLLIYKN
PKLLIYKNYN
KLLIYKNYNRPSGVPDRFSGSKSGTSASLAISGL
LLIYKNYNRPSGVPDRFSGSKSGTSASLAISGLQSEDEAD
IYKNYNRPSGVPDRFSGSK
YNRPSGVPDRFSGSK
PSGVPDRFSGSKSGTSASLAISGLQSEDEADY
PDRFSGSKSG
PDRFSGSKSGTSA
PDRFSGSKSGTSASLAISGLQ
SASLAISGLQSE
LAISGLQSE
QSEDEADYYCSAWDQRQFDVVFGGGTKLTVLGQPK
ADYYCSAWDQRQFDV
YYCSAWDQRQFDVVFGGGTKLT
YYCSAWDQRQFDVVFGGGTKLTVLGQPKAAPSV
YYCSAWDQRQFDVVFGGGTKLTVLGQPKAAPSVTL
AWDQRQFDVVFGGG
AWDQRQFDVVFGGGTKLTVL
DQRQFDVVFGGGTKLTVLGQPKAAPSV
DQRQFDVVFGGGTKLTVLGQPKAAPSVTL
QRQFDVV
FDVVFGGGTKLTVLGQPKAAPSVTLFPPSSEELQA
LTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDF
TVLGQPKAAPSVTLFPPSSEELQANKATLVCL
TVLGQPKAAPSVTLFPPSSEELQANKATLVCLI
LGQPKAAPS
AAPSVTLFPPSSEELQANKAT
PSVTLFPPSSEELQANKATLVCLIS
LFPPSSE
FPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSP
PPSSEELQANKATLVCLISDFYPG
ANKATLVCLISDFYPGAVTVAWKADS
TLVCLISDFYPGAVTVAWKAD
CLISDFYPGAVTVAWKADSSPVKAGVETTTP
ISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNK
VTVAWKADSSPV
AWKADSSPVKAGVETTTPSKQSNNKYAASSY
KADSSPVKAGVETTTPSKQSNNKYAASSYLSLT
ADSSPVKAGVETTTPSK
DSSPVKAGVETTTPSKQSNNKYAAS
PVKAGVETTTPSKQSNNKYAAS
AGVETTTPSKQ
VETTTPSKQSNNKYAASSYLSLTPEQWKSH
TPSKQSNNKYAASSYLSLTPEQWKSHRS
KQSNNKYAASSYLSLTPEQWKSHRS
SNNKYAASSYLSLTPE
ASSYLSLT
ASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPT
LTPEQWKSHRSYS
RSYSCQVTHEGSTVEKTV
# Generated sample - 10881L|abelacimab|Homo sapiens||L-LAMBDA (V-LAMBDA (1-110) [D1] + C-LAMBDA (111-216) [D2])|||||||216|216|||MW undefined|MW undefined| - Alfalytic protease - 50%
PKLLIYKNYNRPS
WDQRQFDV
LGQPKA
DFYPGA
PEQWKS
# Generated sample - 9788H|anetumab ravtansine|Homo sapiens||H-GAMMA-1 (VH (1-120) [D1] + CH1 (121-218) [D2] + CH2 (234-343) [D3] + CH3 (344-448) [D4])|||||||450|450|||MW undefined|MW undefined| - Trypsin - 50%
QVELVQSGAEVK
KPGESLK
GSGYSFTSYWIGWVR
YSPSFQGQVTISADK
SISTAYLQWSSLK
ASDTAMYYCAR
GQLYGGTYMDGWGQGTLVTVSSASTK
STSGGTAALGCLVK
THTCPPCPAPELLGGPSVFLFPPKPK
TPEVTCVVVDVSHEDPEVK
EEQYNSTYR
ALPAPIEK
EPQVYTLPPSR
GFYPSDIAVEWESNGQPENNYK
WQQGNVFSCSVMHEALHNHYTQK
# Generated sample - 9788H|anetumab ravtansine|Homo sapiens||H-GAMMA-1 (VH (1-120) [D1] + CH1 (121-218) [D2] + CH2 (234-343) [D3] + CH3 (344-448) [D4])|||||||450|450|||MW undefined|MW undefined| - Chymotrypsin - 50%
KISCKGSGY
VRQAPGKGL
GIIDPGDSRTRY
QGQVTISADKSISTAY
CARGQL
VTVSSASTKGPSVF
TSGVHTF
ICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPEL
GGPSVF
ISRTPEVTCVVVDVSHEDPEVKF
VDGVEVHNAKTKPREEQY
PAPIEKTISKAKGQPREPQVY
PPSRDEL
TKNQVSL
ESNGQPENNY
DSDGSF
TVDKSRW
# Generated sample - 9788H|anetumab ravtansine|Homo sapiens||H-GAMMA-1 (VH (1-120) [D1] + CH1 (121-218) [D2] + CH2 (234-343) [D3] + CH3 (344-448) [D4])|||||||450|450|||MW undefined|MW undefined| - LysC - 50%
PGESLK
GSGYSFTSYWIGWVRQAPGK
ASDTAMYYCARGQLYGGTYMDGWGQGTLVTVSSASTK
GPSVFPLAPSSK
STSGGTAALGCLVK
DTLMISRTPEVTCVVVDVSHEDPEVK
FNWYVDGVEVHNAK
PREEQYNSTYRVVSVLTVLHQDWLNGK
ALPAPIEK
GFYPSDIAVEWESNGQPENNYK
SRWQQGNVFSCSVMHEALHNHYTQK
SLSLSPGK
# Generated sample - 9788H|anetumab ravtansine|Homo sapiens||H-GAMMA-1 (VH (1-120) [D1] + CH1 (121-218) [D2] + CH2 (234-343) [D3] + CH3 (344-448) [D4])|||||||450|450|||MW undefined|MW undefined| - Aspecific - 50%
ELVQSGAEVKKPGESLKISCKGSGYSFTSY
LVQSGAEVKKPGESLKISCKGSGYSFTSYWIGWVRQA
VQSGAEVKKPGESLKISCKGSGYSFTSYWIGWVRQ
KKPGESLKISC
GESLKISCKGSGYSFTSYWIGWVRQAPGKGLEWMGII
YSFTSYWIG
YSFTSYWIGWVRQAPGK
YWIGWVRQAPGKGLEWMGII
VRQAPGKGLEWMGIIDPGDSRTRYSPSFQGQVTISADKSI
QAPGKGLEWM
QAPGKGLEWMGIIDPGDSRTRYSPSFQG
QAPGKGLEWMGIIDPGDSRTRYSPSFQGQVT
GLEWMGIIDPGDSRTRYSPSFQG
GLEWMGIIDPGDSRTRYSPSFQGQVTISADKSISTAYL
IIDPGDSRTRYSPSFQ
IDPGDSRTRYSPSFQGQVT
PGDSRTRYSPSFQGQV
PSFQGQVTISAD
PSFQGQVTISADKSISTAYLQWSSLKASDT
QVTISADKSISTAYLQWSSLKASDTAMYYCARGQLYGGTY
VTISADKSISTAYLQWSSLKASDTA
ADKSISTAYLQWSSLKASDTAMYYCARGQLYGGTYM
ISTAYLQWSSLKASDTAMY
QWSSLKASDTAMYYCAR
SSLKASDTAMYYCARGQLYGGTYMDGWGQGT
ASDTAMYYCARGQLYGGTYMDG
ASDTAMYYCARGQLYGGTYMDGWG
DTAMYYCAR
MYYCARGQLYGGTY
YCARGQLYGGTYMDGWGQGTLVTVSSASTK
GGTYMDGWGQGTLV
YMDGWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTA
GWGQGTLV
TLVTVSSASTK
SASTKGPSVFPLAPS
SASTKGPSVFPLAPSSKSTSGGTAALGC
TKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWN
SVFPLAPSSK
PSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVH
SKSTSGGTAALGCLVKDYFPEPVTVS
STSGGTAALGC
GTAALGCLVKDYFPEPVTVSWNSGALTSG
LGCLVKD
GCLVKDYFPEPVTVSWNSGALTSG
CLVKDYFPEPVTVSWNSGALTSGVHT
VKDYFPEPVTVSW
YFPEPVT
FPEPVTVSWNSGALTSGVHTFPAVL
TVSWNSGALTSGVHTFPAVLQSS
SWNSGALTSGVHTF
WNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSL
TSGVHTFPAVLQSSGLYSLSSVVTVP
FPAVLQSSGLYSLSSVVTVPSSSLG
PAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTK
AVLQSSGLYSLSSVVTVPSSSLGTQTYICN
LQSSGLYSLSSVVTVP
LQSSGLYSLSSVVTVPSSSLGTQTYICNVNHK
SSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSN
VTVPSSSLGTQTYICN
SLGTQTY
LGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPA
QTYICNVNHKPSNTKVDKK
CNVNHKP
NVNHKPSNTKVDKKVEPKSCDKTHTCP
NTKVDKKVEPKSCDKTHTCPPCPAPELLG
DKKVEPKSCDKTHTCPPCPA
DKKVEPKSCDKTHTCPPCPAPELL
VEPKSCDKT
SCDKTHT
THTCPPCPAPELLGGPSVF
HTCPPCPAPELLGGPSVFLFPPKPKDTLM
PCPAPELLGGPSVFLFPPKPKDT
PCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVV
PAPELLGGPSVFLFPPKPKDTLMISR
APELLGGPSVFLFPPKPKDTLMISRTPEVTCVV
PSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKF
FLFPPKPKDTLMISRTPEVTCV
PKDTLMISRTPEVTCVVVDVSHEDPEV
TLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAK
LMISRTPEVTCVVVDVSHED
SRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNA
VTCVVVDV
CVVVDVSHEDPEVKFNWYVD
CVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPRE
VVDVSHEDP
VVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYN
VDVSHEDPEVKFNWYVDGVE
VDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTY
DVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTY
EDPEVKFNWYVDGVE
PEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTV
KFNWYVDGVEVHNAKT
VEVHNAKTKPREEQYNS
KTKPREEQYNSTYRVVSVLTVLHQDWLNG
QYNSTYRVVSVLTVLHQDW
NSTYRVVSVLTVLHQDWLNGKEY
VVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTIS
LTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKG
TVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQP
VLHQDWLNGKEYKCKVS
VLHQDWLNGKEYKCKVSNKALPAPIEKTISKAK
HQDWLNGK
GKEYKCKVSNKAL
YKCKVSNKALPAPIE
PIEKTISKA
SKAKGQP
KAKGQPREPQVYTLPPSRDELTKNQVSLTCLVKG
QVYTLPPSRDELTK
QVYTLPPSRDELTKNQVSLTCLVKGFYPSDIAVEW
VYTLPPSRDELTKNQVSLT
DELTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNY
ELTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTP
SLTCLVK
TCLVKGFYPSDIAVEWESN
LVKGFYPSDIAVEWESNGQPENNYKTTP
GFYPSDIAVEWESNGQPENNYKTTPPVLDSDGS
EWESNGQPENNYKTTPPVLDS
PENNYKTTPPVLDSDGSFFLYSK
NYKTTPPVLDSDGSFFLYSKLTVDKSRWQQ
PPVLDSDGSFFLYSKLTVD
PVLDSDGSFFLYS
LDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMH
LDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHN
GSFFLYSKLTVDKSRWQQGNVFS
FFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQ
FLYSKLTVDKSRWQQGNVFSCSVMHEALHNH
LYSKLTVDKSRWQQGNVFSCSVMHEALHNHYT
YSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKS
TVDKSRWQQGNVFSCSVMHEALH
TVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG
VDKSRWQQGNVFSCSVMHEALHNHYTQKSL
DKSRWQQGNVFS
KSRWQQGNVFSCSVMHEALHNHYTQKSLSL
RWQQGNVFSCSVMHEALHNHYTQ
QGNVFSCSV
CSVMHEALHNHYTQKSLSLS
NHYTQKSLSLSPG
HYTQKSLS
# Generated sample - 9788H|anetumab ravtansine|Homo sapiens||H-GAMMA-1 (VH (1-120) [D1] + CH1 (121-218) [D2] + CH2 (234-343) [D3] + CH3 (344-448) [D4])|||||||450|450|||MW undefined|MW undefined| - Alfalytic protease - 50%
KKPGES
YWIGWV
YMDGWGQGT
CPPCPA
PELLGGPS
FLFPPKPKDT
KFNWYV
KPREEQYNS
RWQQGNV
# Generated sample - 9788L|anetumab ravtansine|Homo sapiens||L-LAMBDA (V-LAMBDA (3-111) [D1] + C-LAMBDA (112-217) [D2])|||||||217|217|||MW undefined|MW undefined| - Trypsin - 50%
LTVLGQPK
GDSSPVK
AGVETTTPSK
SYSCQVTHEGSTVEK
TVAPTECS
# Generated sample - 9788L|anetumab ravtansine|Homo sapiens||L-LAMBDA (V-LAMBDA (3-111) [D1] + C-LAMBDA (112-217) [D2])|||||||217|217|||MW undefined|MW undefined| - Chymotrypsin - 50%
QQHPGKAPKL
GVNNRPSGVSNRF
SGSKSGNTASL
QAEDEADY
GGGTKL
QANKATL
# Generated sample - 9788L|anetumab ravtansine|Homo sapiens||L-LAMBDA (V-LAMBDA (3-111) [D1] + C-LAMBDA (112-217) [D2])|||||||217|217|||MW undefined|MW undefined| - LysC - 50%
ATLVCLISDFYPGAVTVAWK
GDSSPVK
# Generated sample - 9788L|anetumab ravtansine|Homo sapiens||L-LAMBDA (V-LAMBDA (3-111) [D1] + C-LAMBDA (112-217) [D2])|||||||217|217|||MW undefined|MW undefined| - Aspecific - 50%
DIALTQPASVSGSPGQSITISCTGTSSDIGGYN
LTQPASVSGSPGQSITIS
LTQPASVSGSPGQSITISCTGT
TQPASVSGSPGQSITISCTGTSSDI
ASVSGSPGQSITISCTGTSSDIGGY
ASVSGSPGQSITISCTGTSSDIGGYNSVSWYQQHPGK
VSGSPGQSITISCTG
VSGSPGQSITISCTGTSS
SGSPGQSITISCTGTSSDIGGYNSVSWYQQHPGKA
SPGQSITISCTGTSSDIGGYN
PGQSITISCTGTSSD
ITISCTGTSSDIGGYNSV
ITISCTGTSSDIGGYNSVSWYQQHPGKAPKLM
TISCTGTSSDIGGYN
ISCTGTSS
CTGTSSDIGGYNSVSWYQQHPGKA
CTGTSSDIGGYNSVSWYQQHPGKAPKLMIY
SDIGGYNSVSWYQQHPGKAPKLMIYGVNNRPSGVSNRFSG
DIGGYNSVSWYQQ
DIGGYNSVSWYQQHPGKA
GYNSVSWYQQHPGKA
GYNSVSWYQQHPGKAPKLMIY
YNSVSWYQQHPGKAPKLMIYGVNNRPSGVSNRFSGSKS
NSVSWYQQHPGKA
WYQQHPGKAPKLMIYGVNNRPSGVSNR
KAPKLMIYGVNNRPSGVSNRFSGSKSGNTASLTISG
APKLMIYGVNNRPSGVSNRFSGSKSGNTASLT
PKLMIYGVNNRPSGVSNRFSGSKSGNT
LMIYGVNNRPSGVSNRFSGSKSGNTASLTISGLQ
MIYGVNNRPSGVSNRFSGSKSGNTAS
GVNNRPSGVSNRFSGSKSGN
NNRPSGVSNRFSGSKSGNTA
PSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYDIE
GVSNRFSGSKSGNTASLT
NRFSGSKSGNTASL
NRFSGSKSGNTASLTISGLQAEDEADYYCSSYDIE
FSGSKSGNTASLTIS
GSKSGNTASLTISG
ASLTISGLQAEDEADYYCSSYDIESA
LTISGLQAEDEADYYC
GLQAEDEADYYCSSYDIESATPVFGGG
AEDEADYYCSSYDIESATPVFGGGT
AEDEADYYCSSYDIESATPVFGGGTKLTVLG
SATPVFGGGTKLT
PVFGGGTKLTVLGQPKAAPSVT
VFGGGTKLTVLGQPKAA
GGGTKLTVLGQ
GTKLTVLGQPKAA
LTVLGQPKAAPSVT
LGQPKAAP
GQPKAAP
KAAPSVTLFPPSSEELQANKATLVCLIS
FPPSSEELQANKATL
SSEELQANKA
SSEELQANKATLVCLISDFYPGAVTV
NKATLVCLISDFYPGAVTVAWKGDSSPVKAGVETTTPSKQ
KATLVCLISDFYPGA
ATLVCLISDFYPGAVTVAWKGDSSPVKAGVETTTPSKQ
TLVCLISDFYPGAVTVAWKGDSSPVKAGVET
LVCLISDFYPGAVTVAWKGDSSPV
AVTVAWKGDSSPVKAGVETTTPSKQSNNKYAASSYLSLTP
TVAWKGDSSPVKAGV
AWKGDSSPVKAGVETTTPSKQSNNKYAASS
DSSPVKAGVETTTPSKQSNNKYAASSY
SSPVKAGVETTTPSKQSNNKYAA
PVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHR
ETTTPSKQSNNKYA
TTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGS
TTPSKQSNNKYAASSYLSLTP
QSNNKYAASSYLSLTPEQWKSH
NNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTV
SSYLSLTP
TPEQWKSHRS
RSYSCQVTHEGS
VTHEGSTVEKTVAPTE
HEGSTVEKTVAPTECS
# Generated sample - 9788L|anetumab ravtansine|Homo sapiens||L-LAMBDA (V-LAMBDA (3-111) [D1] + C-LAMBDA (112-217) [D2])|||||||217|217|||MW undefined|MW undefined| - Alfalytic protease - 50%
DIGGYNS
WYQQHPGKA
DFYPGA
PEQWKS
# Generated sample - 9921H|abrilumab|Homo sapiens||H-GAMMA-2 (VH (1-118) [D1] + CH1 (119-216) [D2] + CH2 (229-337) [D3] + CH3 (338-442) [D4])|||||||444|444|||MW undefined|MW undefined| - Trypsin - 50%
KPGASVK
VSGYTLSDLSIHWVR
GLEWMGGFDPQDGETIYAQK
STSESTAALGCLVK
DTLMISR
VVSVLTVVHQDWLNGK
GLPAPIEK
EPQVYTLPPSR
NQVSLTCLVK
WQQGNVFSCSVMHEALHNHYTQK
SLSLSPGK
# Generated sample - 9921H|abrilumab|Homo sapiens||H-GAMMA-2 (VH (1-118) [D1] + CH1 (119-216) [D2] + CH2 (229-337) [D3] + CH3 (338-442) [D4])|||||||444|444|||MW undefined|MW undefined| - Chymotrypsin - 50%
VQSGAEVKKPGASVKVSCKVSGY
VRQAPGKGL
DPQDGETIY
KSEDTAVY
CATGSSSSW
APCSRSTSESTAAL
PEPVTVSW
SSVVTVPSSNF
PAPIEKTISKTKGQPREPQVY
TKNQVSL
ESNGQPENNY
DSDGSF
TVDKSRW
# Generated sample - 9921H|abrilumab|Homo sapiens||H-GAMMA-2 (VH (1-118) [D1] + CH1 (119-216) [D2] + CH2 (229-337) [D3] + CH3 (338-442) [D4])|||||||444|444|||MW undefined|MW undefined| - LysC - 50%
QVQLVQSGAEVK
SEDTAVYYCATGSSSSWFDPWGQGTLVTVSSASTK
GPSVFPLAPCSRSTSESTAALGCLVK
CCVECPPCPAPPVAGPSVFLFPPK
SRWQQGNVFSCSVMHEALHNHYTQK
# Generated sample - 9921H|abrilumab|Homo sapiens||H-GAMMA-2 (VH (1-118) [D1] + CH1 (119-216) [D2] + CH2 (229-337) [D3] + CH3 (338-442) [D4])|||||||444|444|||MW undefined|MW undefined| - Aspecific - 50%
QVQLVQSGAEVKK
VQSGAEVKKPGASVKVS
QSGAEVKKPGASVKVSCKVSGYTLSDLSIHWVRQAPG
AEVKKPGASVKVSCKVSGYTLSDL
AEVKKPGASVKVSCKVSGYTLSDLSIHWVRQA
ASVKVSC
ASVKVSCKVSGYTLSDLSIHWVRQAPGKG
VKVSCKVSGYTLSDLSIHWVRQAPGKGLEW
VSGYTLSDLSIHWVRQAPGKGLEWMGGFDPQDGETIYA
YTLSDLSIHWVRQA
LSIHWVRQAPGKGLEWMGGFDPQDGETIYAQKFQ
SIHWVRQAPGKGLEWMGGFDPQDGETIYAQKFQGRVT
IHWVRQAPGKGLEWMGGFD
IHWVRQAPGKGLEWMGGFDPQDGETIYAQKFQGRV
RQAPGKGLEWMGGFDPQDGE
KGLEWMGGFDPQDGETIYAQ
LEWMGGFDPQDGETIYAQKF
EWMGGFD
EWMGGFDPQDGETIYAQKFQGRVTMTEDTSTDTA
WMGGFDP
MGGFDPQD
GFDPQDGETIYAQKFQGRVTMTEDTST
GFDPQDGETIYAQKFQGRVTMTEDTSTDTAYM
QDGETIYAQKFQGRVTMTEDTSTDTAYMEL
DGETIYAQKFQGRVTMTEDTSTDTAYMELSS
GETIYAQKFQGRVTMTEDTSTDTA
TIYAQKFQ
IYAQKFQGRV
IYAQKFQGRVTMTEDTST
AQKFQGRVTMTEDTSTDTAYMELS
AQKFQGRVTMTEDTSTDTAYMELSSLKSEDTAVYYCATGS
QKFQGRVTMTEDTSTDTAYMELSSLKSEDT
QGRVTMTEDTSTDTAYMELSSLKSEDTAVY
GRVTMTE
TEDTSTDTAYMELSSL
DTSTDTAYMELSSLKSEDTAVYYCATGSS
TDTAYMELSSLKSEDTAVYYCATGSSSSWFDPW
TAYMELSSLKSE
AYMELSS
AYMELSSLKSEDTAVYYCATGSSSSWFDPWGQGTLVTVSS
LSSLKSEDTAV
LSSLKSEDTAVYYCATGSSSSWFD
SSLKSEDTAVYYCATGSSSSWFDPWGQGTLVTVSS
SLKSEDTAVYYCATGSSSSWFDPWGQGTLVTVSSAS
SEDTAVYY
AVYYCATGSSSSWFDPWGQGTLVTVSSASTKGP
YCATGSSSSWFDPWGQGTLVTVSSASTKGPS
SSWFDPWGQGT
WFDPWGQGTLVTVSSASTKGPSVF
LVTVSSASTKGPSVFPLAPCSRSTSESTAALGCL
ASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPV
FPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNS
PCSRSTS
SRSTSESTAALG
TSESTAALGCLVKDYFPEPVTVSWNSGALTSGVH
TAALGCLVKDYFPEPVTVSWNSGALT
TAALGCLVKDYFPEPVTVSWNSGALTSGVHTF
AALGCLVKDYFPE
ALGCLVK
ALGCLVKDYFPEPVTVSWN
CLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLS
VKDYFPEPVTVSWNSGALTSGV
PEPVTVSWNSGALT
VSWNSGALTSGVHTFPAV
SWNSGALTSGVHTFPAV
SWNSGALTSGVHTFPAVLQSSGLYS
WNSGALTSGVHTFPAVLQSSGLYS
SGALTSGVHTFPAVLQSSGLY
VHTFPAVLQSSGLYSLSSV
PAVLQSSGLYSL
AVLQSSGLYSLSSVVTVPSSN
VLQSSGLYSLSSVVTVPSSNF
VLQSSGLYSLSSVVTVPSSNFGTQT
QSSGLYSLSSVVTVPSSNFGTQTYTCNVDH
SSGLYSLSSVVTVPSSNFGTQTYTCNVDHKPSNTKVDKT
VTVPSSNFGTQTYTCNVDHKPS
PSSNFGT
PSSNFGTQTYTCNVDHKPSNTKVD
SNFGTQTYTCNVDHKPSNTKVDKTVERKC
TYTCNVDHKPSNTKVDKTVERKCCV
YTCNVDHKPSNTKVDKTVERKCCVECPPCP
DHKPSNTKVDKTV
SNTKVDKTVERKCCVECPPCPAPPVAGPSVFLF
NTKVDKT
KVDKTVERKCCVECPPCPAPPVAGPSVFLFPPK
KVDKTVERKCCVECPPCPAPPVAGPSVFLFPPKPKDTL
VDKTVERKCCVECPPCPAPPVAGPSVFLFPPKPK
VERKCCVECPPCP
ERKCCVECPPCPAPPVAGPSVFLFPPK
CPAPPVAGPSVFLFPPKPKDTLMISRTPEVTCV
PSVFLFPPKPK
MISRTPEVTCVVVDVSHE
SRTPEVTCVVVDVS
RTPEVTCVVVDVSHEDP
PEVTCVVVDVSHED
TCVVVDVSHEDPEVQFNWYV
EVQFNWYVDGVEVHNAKT
VQFNWYVDGVEVHNAKTKPREEQFNSTFRVVSVLTVVHQ
QFNWYVDGVEVHNAKTKPREEQFNST
YVDGVEVHN
GVEVHNAKTKPREEQFNSTFRVVSVLTVVHQ
EVHNAKTKPREEQFNSTFRVVSVLTVVHQDWLNGK
VHNAKTKPRE
VHNAKTKPREEQFNSTF
NAKTKPREEQFNSTFRVVSVLTVVHQD
AKTKPREEQFNSTFRVVSVLTVVH
PREEQFN
REEQFNSTFRVVSVLT
FNSTFRVVSVLTVVHQDW
FRVVSVLTVVHQDWLNGKEYKCKVSNKGLPAP
WLNGKEYKCKVSNKGLPAPIEKT
LNGKEYKCKVSNKGLPAPIEKT
NGKEYKCKVSNKGLPAPIEKTISK
EYKCKVSNKGLPAPIEKTISKTKGQPREPQVYTLPPS
KCKVSNKGLPAPIEKTISKTKGQPREPQVY
KVSNKGLPAPIEKTISKTKGQPREPQ
VSNKGLPAPIEKTISKTKGQP
VSNKGLPAPIEKTISKTKGQPREPQVYT
EKTISKTKGQPREPQVYTLPPSREE
KTKGQPREPQVYTLPPSR
TKGQPREPQVYTLPPSREEMT
TKGQPREPQVYTLPPSREEMTKNQVSL
REPQVYTLPPSREEMTKNQVSL
REPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWE
PSREEMTKNQVSLTCL
SREEMTKNQVSLTCLVKGFYPSDIAV
NQVSLTCLVKGFY
VKGFYPSDIAVEWESNGQPENNYKTTPPMLDSDGSFFLYS
KGFYPSDIAVEWESNGQPENNYKTTPPMLDSDGS
GFYPSDIAVEWESNGQPENNYKTTPPML
EWESNGQPENN
WESNGQPENNYKTTPP
WESNGQPENNYKTTPPMLDSDGSFFLYSKL
ESNGQPENNYKTTPPMLDSDGSFFLYSKLTVDKSRWQQGN
NGQPENNYKTTPPMLDSDGSFFLY
GQPENNYKTTPPMLDSDGSFFLYSKLT
NNYKTTPPMLDSDGSFFLYSKLTVDKSR
NNYKTTPPMLDSDGSFFLYSKLTVDKSRWQQG
YKTTPPMLDSDGS
PPMLDSDGSFFLYSKLTVDKSRWQQ
PMLDSDGSFFLYSKLTVDKSRWQQGNVFS
SDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEAL
DGSFFLYSKLTVDKSRWQQGNVF
SFFLYSKLTVDK
LYSKLTVDKSR
LYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSL
YSKLTVDKSRWQQGNVFSC
SKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKS
TVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG
KSRWQQG
KSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG
VFSCSVMHEALHNHYT
# Generated sample - 9921H|abrilumab|Homo sapiens||H-GAMMA-2 (VH (1-118) [D1] + CH1 (119-216) [D2] + CH2 (229-337) [D3] + CH3 (338-442) [D4])|||||||444|444|||MW undefined|MW undefined| - Alfalytic protease - 50%
QKFQGRV
ECPPCPA
HEDPEV
KPREEQFNS
HQDWLNGKEYKCKV
NKGLPA
NGQPENNYKT
# Generated sample - 9921L|abrilumab|Homo sapiens||L-KAPPA (V-KAPPA (1-107) [D1] + C-KAPPA (108-214) [D2])|||||||214|214|||MW undefined|MW undefined| - Trypsin - 50%
DIQMTQSPSSVSASVGDR
VTITCR
LLIYGASNLESGVPSR
TVAAPSVFIFPPSDEQLK
SGTASVVCLLNNFYPR
# Generated sample - 9921L|abrilumab|Homo sapiens||L-KAPPA (V-KAPPA (1-107) [D1] + C-KAPPA (108-214) [D2])|||||||214|214|||MW undefined|MW undefined| - Chymotrypsin - 50%
PREAKVQW
EKHKVY
ACEVTHQGL
SSPVTKSF
# Generated sample - 9921L|abrilumab|Homo sapiens||L-KAPPA (V-KAPPA (1-107) [D1] + C-KAPPA (108-214) [D2])|||||||214|214|||MW undefined|MW undefined| - LysC - 50%
DIQMTQSPSSVSASVGDRVTITCRASQGISSWLAWYQQK
VDNALQSGNSQESVTEQDSK
DSTYSLSSTLTLSK
VYACEVTHQGLSSPVTK
# Generated sample - 9921L|abrilumab|Homo sapiens||L-KAPPA (V-KAPPA (1-107) [D1] + C-KAPPA (108-214) [D2])|||||||214|214|||MW undefined|MW undefined| - Aspecific - 50%
IQMTQSPSSVSASVGDRVTITCRASQG
QMTQSPSSVSASVGDRVT
QMTQSPSSVSASVGDRVTITCRASQGISSWLAWYQ
ASVGDRVTITCRASQGISSWLAWYQQKPG
SVGDRVTITCRAS
VGDRVTITCRASQGISSWLAWYQQKPGKAP
GDRVTITCRASQGI
VTITCRA
VTITCRASQGISSWLAWYQQKPGKAPKLLIYG
ITCRASQGISSWLAWYQQKPGKAPK
QGISSWLAWYQQKPGKAPKLLIYGASNLE
ISSWLAWYQQK
WLAWYQQKPGKAPKLLIYGASNLES
KPGKAPKLLIYGASNLESG
PGKAPKLLIYGASNLESGVPSRFSGS
GKAPKLLIYGASNLESGVPS
GKAPKLLIYGASNLESGVPSRFSGSGSGTD
KAPKLLIYGASNLESGVPSRFSGSGSGTDFTLTISSLQPE
LLIYGASNLESGVPSRFSGSGSGTDFTLTISSL
ESGVPSRFSGSGSGTDFTLTISSLQPEDFANY
SRFSGSG
SRFSGSGSGTDFTLTISSLQPEDF
RFSGSGSG
FSGSGSGTDFTLTIS
FSGSGSGTDFTLTISSLQ
SGTDFTLTISSLQPEDFA
FTLTISSLQPEDFANYYCQQANSFPWTF
TISSLQPEDFANY
SLQPEDFAN
LQPEDFANYYCQQANSFPWTFG
LQPEDFANYYCQQANSFPWTFGQGTKVEIKRT
LQPEDFANYYCQQANSFPWTFGQGTKVEIKRTVA
QPEDFANYYCQQANSFPWTFGQGTKVEIKRTVAA
EDFANYYCQQANSFPWTFGQGTKVEIKRTVAA
DFANYYCQQANSFPWTFGQ
FANYYCQQAN
YYCQQANSFPWTFGQGTKVE
ANSFPWTFGQGTKVEIKRTVAAPSVFIFPPSDEQLK
PWTFGQGTKVEIKRTVAAPSVFIF
TFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVC
GTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLN
KVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPR
IKRTVAAPSVFIFPPSDEQLKSGTASVV
KRTVAAPSVFIFPP
KRTVAAPSVFIFPPSDEQL
KRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREA
AAPSVFIFPPSDEQLKSGTASVVCLLNNF
PSVFIFPPSDEQLKSGTASVV
SVFIFPPSDEQLKSGTA
VFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNA
FPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSG
PPSDEQLKSGTASVVCLLNN
PSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNA
DEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSG
ASVVCLLNNFY
VCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDS
LLNNFYPREAKVQW
YPREAKVQWKVDNALQSGNSQESVTEQDSK
AKVQWKVDNALQSGNSQESVTEQDSKD
AKVQWKVDNALQSGNSQESVTEQDSKDSTYS
WKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSK
ALQSGNSQE
ESVTEQDS
SVTEQDSKDSTY
QDSKDSTYSLSSTLTL
TLTLSKADYEKHKVYAC
LSKADYEKHKVYACEVTHQGLSSPVTKSFNRG
DYEKHKVYA
VYACEVTHQGLSSPVT
SSPVTKSFNRGE
# Generated sample - 9921L|abrilumab|Homo sapiens||L-KAPPA (V-KAPPA (1-107) [D1] + C-KAPPA (108-214) [D2])|||||||214|214|||MW undefined|MW undefined| - Alfalytic protease - 50%
WYQQKPGKA
PKLLIYGA
NYYCQQA
DEQLKS
DYEKHKV
# Generated sample - 10106H|ascrinvacumab|Homo sapiens||H-GAMMA-2 (VH (1-118) [D1] + CH1 (119-216) [D2] + CH2 (229-337) [D3] + CH3 (338-442) [D4])|||||||444|444|||MW undefined|MW undefined| - Trypsin - 50%
GLEWIGYIYYSGSTYYNPSLK
VTISVDTSK
LSSVTAADTAVYYCAR
ESVAGFDYWGQGTLVTVSSASTK
STSESTAALGCLVK
DTLMISR
EEQFNSTFR
GLPAPIEK
EPQVYTLPPSR
NQVSLTCLVK
GFYPSDIAVEWESNGQPENNYK
TTPPMLDSDGSFFLYSK
# Generated sample - 10106H|ascrinvacumab|Homo sapiens||H-GAMMA-2 (VH (1-118) [D1] + CH1 (119-216) [D2] + CH2 (229-337) [D3] + CH3 (338-442) [D4])|||||||444|444|||MW undefined|MW undefined| - Chymotrypsin - 50%
VKPSQTL
TCTVSGGSISSGEY
SSVTAADTAVY
PEPVTVSW
PPKPKDTL
ISRTPEVTCVVVDVSHEDPEVQF
RVVSVL
TVVHQDW
PAPIEKTISKTKGQPREPQVY
# Generated sample - 10106H|ascrinvacumab|Homo sapiens||H-GAMMA-2 (VH (1-118) [D1] + CH1 (119-216) [D2] + CH2 (229-337) [D3] + CH3 (338-442) [D4])|||||||444|444|||MW undefined|MW undefined| - LysC - 50%
QVQLQESGPGLVK
PSQTLSLTCTVSGGSISSGEYYWNWIRQHPGK
GLEWIGYIYYSGSTYYNPSLK
NQFSLK
LSSVTAADTAVYYCARESVAGFDYWGQGTLVTVSSASTK
GPSVFPLAPCSRSTSESTAALGCLVK
CCVECPPCPAPPVAGPSVFLFPPK
PREEQFNSTFRVVSVLTVVHQDWLNGK
GLPAPIEK
GQPREPQVYTLPPSREEMTK
NQVSLTCLVK
GFYPSDIAVEWESNGQPENNYK
SLSLSPGK
# Generated sample - 10106H|ascrinvacumab|Homo sapiens||H-GAMMA-2 (VH (1-118) [D1] + CH1 (119-216) [D2] + CH2 (229-337) [D3] + CH3 (338-442) [D4])|||||||444|444|||MW undefined|MW undefined| - Aspecific - 50%
QVQLQESGPGLVKPSQTLSLTCTVSGGSISS
QLQESGPGLVKPSQTLSLTCTVSGGSISSGEYYWN
QLQESGPGLVKPSQTLSLTCTVSGGSISSGEYYWNWI
ESGPGLVKPSQTLSLTCTVSGGSI
ESGPGLVKPSQTLSLTCTVSGGSISSGEYYWN
SGPGLVKPS
LVKPSQTLSLTCTVSGGSISSGEYYWNWIRQHPGKG
SQTLSLTCTVSGGSISSGEYYWNWIRQHPGKGLEWIGYIY
SISSGEY
EYYWNWIRQHPGKG
YWNWIRQHPGKGLEWIGYIYYSGSTYYNPS
WNWIRQHPGKGLE
WIRQHPGKGLEWIGYIYYSGSTYYN
IRQHPGKG
IRQHPGKGLE
RQHPGKGLEWIGYIYYSGSTYYNPSLKSRVTISVDTS
QHPGKGLE
HPGKGLEWIGYIYY
GLEWIGYI
LEWIGYIYYSGSTYYNPSLKSRVTISVDTSKNQFS
WIGYIYYSGSTYYNPSLKSRV
YYSGSTYYNPSLKS
YNPSLKSRVTISVDTSK
NPSLKSR
NPSLKSRVTISVDTSKNQFSLKLSSVTAADTAV
SLKSRVTISVDTSKNQ
RVTISVD
ISVDTSKNQFSLKLSSVTAADTAVYYCARES
DTSKNQFSLKLSSVTAADTAVYYCARESVAG
SKNQFSLKLSSVTAADTAVYYCA
NQFSLKLSSVTAADTAVYYCARESVAGFDYWGQGTLVT
KLSSVTAADTAVYYCARESVAGFDYWGQGTLVTVSSAST
SSVTAADTAVYY
SVTAADTAVYYCAR
TAADTAVY
YYCARESVAGFDYWGQGTLVTVSSA
YYCARESVAGFDYWGQGTLVTVSSASTKGPSVFPLAPCSR
AGFDYWGQGTLVTVSSA
GFDYWGQGTLVTVSSAS
GFDYWGQGTLVTVSSASTKGPSVFPLAPCSRSTS
FDYWGQGTLVTVSSASTKGPSVFPLAPCSRSTSESTAAL
DYWGQGTLVTVSSASTKGP
GTLVTVSSASTKGPSVFPLAPCSRSTSE
VTVSSASTKGP
VTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDY
TVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKD
SASTKGPSVFPLAPCSRSTSESTAALGC
VFPLAPCSRSTSESTAALG
PLAPCSRSTSESTAALGCLV
PLAPCSRSTSESTAALGCLVKDYFP
CSRSTSEST
SRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHT
TSESTAALGCLV
CLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYS
LVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLS
VTVSWNSGALT
VTVSWNSGALTSGVHTFPAVLQSSGLYS
WNSGALTSGVH
NSGALTS
LTSGVHTFPAVLQSSGLYSLSSVVTVPSSNFGTQTYTC
VHTFPAVLQSSGL
VHTFPAVLQSSGLY
TFPAVLQSSGLYSLSSVVTV
FPAVLQSSGLYS
PAVLQSSGL
LYSLSSVVTVPSS
TVPSSNFGT
PSSNFGTQTYTCNVDHKPS
SNFGTQTYTCNV
NFGTQTYTCNVDHKPSNT
QTYTCNVDH
TCNVDHKPSNTKVDKTVERKCCVECPP
CNVDHKPSNTKVDKTVERKCCVECPPCPAPPVAGPSV
HKPSNTK
HKPSNTKVDKTVERKCCVECPPCPAPP
HKPSNTKVDKTVERKCCVECPPCPAPPVAGP
PSNTKVDKTVERKCCVECPPC
KTVERKCCVECPPCPA
ERKCCVECPPCPAPPVAGPS
ECPPCPAPPVAGPSVFLFPPKPKDTLMISRT
PCPAPPV
CPAPPVAGPSVFLFPPKPKDTLMISRTPEVTCVVV
PAPPVAGPSVFLFPPKPK
APPVAGPSVFLFPPKPKD
APPVAGPSVFLFPPKPKDTLMISRTPE
PPVAGPSVFLFPPKPKDTL
PVAGPSVFLFPPKPKDTLMIS
PVAGPSVFLFPPKPKDTLMISRTPEVTCVV
VAGPSVFLFPPKPKDTLMISRTPEVTCVVVD
PKPKDTLMISRTPEVTCVVVDVS
DTLMISRTPEVTCVVVD
MISRTPEV
MISRTPEVTCVVVDV
RTPEVTCV
PEVTCVVVDVSHEDP
EDPEVQFN
EDPEVQFNWYVDGVEVHNAKTKPREEQFNST
PEVQFNWYVDGV
VQFNWYVDGVEVHNAKTKPREEQFNSTFRVVSVLTV
YVDGVEVHNAK
VDGVEVHNAKTKPREEQFNSTFRVVSVLTVVHQDW
DGVEVHNAK
EVHNAKTKPREE
NAKTKPR
AKTKPREEQFNSTF
KTKPREEQFNSTFRVVSVLTVVH
TKPREEQFNSTFRVVSVLTVVHQDWLNGK
EEQFNSTFR
STFRVVSVLTVVHQDWLNGKEYKCKVSNKGLPA
RVVSVLTVVHQDWL
SVLTVVHQDWLNGKEYKCKV
LTVVHQDWLNGKEYKCKVSNKGLPAPIEKTISKTKG
VVHQDWLNGKEYKCKV
VHQDWLNGKEY
HQDWLNGKEYKCKVSNKGLPAPI
WLNGKEYKCKVSNKGLPAPIEKTISKTKGQ
LNGKEYKCKVSNKGLPAPIEKTISKTKGQPR
EYKCKVSNKGLPAPIEKTISKTKGQPREPQVYTLPPS
VSNKGLPAPIEKTISKTKGQPREPQVYTLPPSREEMTKN
SNKGLPAP
APIEKTISKTKGQPREPQVYTLPPSREEMTKNQVSLTC
IEKTISKTKGQPREPQVYTLPPSREEMTKNQVSLTCLVK
KTISKTKGQPREPQV
QPREPQVYTLPPSREEMTKNQVSLTCLVKG
REPQVYTLPPSREEMTKNQVSLTC
EPQVYTLPPS
VYTLPPSREEMTKN
VYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQ
SREEMTKNQVSLTCLVKGFYPSDIAVEW
EEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPE
FYPSDIAVEW
FYPSDIAVEWESNGQPENNYKTTPPMLDSDGSFF
YPSDIAVEWESNGQPENNYK
SDIAVEWESNGQPENNYKTTPPMLDSDG
DIAVEWESNGQ
DIAVEWESNGQPENNYKTTPPMLDSDGSF
IAVEWESNGQPENNYKTTPPMLDSDGSFFLYSKLTVDK
WESNGQPENNYKTT
NGQPENNYKTTPPMLDSDGSFFLYSKLTVDK
PENNYKTTPPMLDSDGSFFLYSKLTVDKSRWQQGN
NNYKTTPPMLDSDGSFFLYSKLTVDK
KTTPPMLDSDGSFFLYSKLTVDKSRWQQG
PMLDSDGSFFLYSKLTVDKSR
MLDSDGSFFLYSKLTVDKS
FFLYSKLTVDKSRWQQGNVFSCSVMHEALHNH
FLYSKLTVDKSRWQQGNVFSCSVMHEAL
KLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSL
DKSRWQQ
WQQGNVFSCSVM
QGNVFSCSVMHEALHNHYTQKSLSLSPGK
# Generated sample - 10106H|ascrinvacumab|Homo sapiens||H-GAMMA-2 (VH (1-118) [D1] + CH1 (119-216) [D2] + CH2 (229-337) [D3] + CH3 (338-442) [D4])|||||||444|444|||MW undefined|MW undefined| - Alfalytic protease - 50%
GEYYWNWIRQHPGKGLEWIGYIYYS
GFDYWGQGT
ECPPCPA
KPREEQFNS
HQDWLNGKEYKCKV
NKGLPA
KGFYPS
# Generated sample - 10106L|ascrinvacumab|Homo sapiens||L-KAPPA (V-KAPPA (1-108) [D1] + C-KAPPA (109-215) [D2])|||||||215|215|||MW undefined|MW undefined| - Trypsin - 50%
EIVLTQSPGTLSLSPGER
ASQSVSSSYLAWYQQKPGQAPR
LLIYGTSSR
TVAAPSVFIFPPSDEQLK
VDNALQSGNSQESVTEQDSK
DSTYSLSSTLTLSK
# Generated sample - 10106L|ascrinvacumab|Homo sapiens||L-KAPPA (V-KAPPA (1-108) [D1] + C-KAPPA (109-215) [D2])|||||||215|215|||MW undefined|MW undefined| - Chymotrypsin - 50%
TQSPGTL
SPGERATL
QQKPGQAPRL
EIKRTVAAPSVF
PPSDEQL
KSGTASVVCL
KVDNAL
QSGNSQESVTEQDSKDSTY
EKHKVY
# Generated sample - 10106L|ascrinvacumab|Homo sapiens||L-KAPPA (V-KAPPA (1-108) [D1] + C-KAPPA (109-215) [D2])|||||||215|215|||MW undefined|MW undefined| - LysC - 50%
VYACEVTHQGLSSPVTK
# Generated sample - 10106L|ascrinvacumab|Homo sapiens||L-KAPPA (V-KAPPA (1-108) [D1] + C-KAPPA (109-215) [D2])|||||||215|215|||MW undefined|MW undefined| - Aspecific - 50%
IVLTQSPGTLSLSPGERATLSCRASQS
SPGTLSLSPGERATLSCRAS
PGTLSLSPGERATLSCRAS
GERATLSCRASQSV
SCRASQSVSSSYLAWYQ
CRASQSVSSSYLAWYQQKP
ASQSVSSSYLAWYQQKPGQAPRLLIYG
SQSVSSSYLAWYQQKPGQAPRLLIYGTSSRATGIPDRFSG
QSVSSSYL
SSYLAWYQQKPGQAPRLLIYGTSSRATGIPDRFSGSG
WYQQKPGQAPRLLIYGTSS
YQQKPGQAPRLLIYGTSSRATGIPDRFSGSGSGTDFTL
QQKPGQAPRLLIYGTSSRATGIPDRFSGSGSGTDF
QQKPGQAPRLLIYGTSSRATGIPDRFSGSGSGTDFTL
PGQAPRLLIYGTSSRATGIPDRFSGSGSGTDFTLTI
APRLLIYGTSSRAT
LLIYGTS
IYGTSSRATGIPDRFSGSGS
GTSSRATGIPDRF
RATGIPDRFSGSG
GIPDRFSGSGSGTDFTLTISRLE
GIPDRFSGSGSGTDFTLTISRLEPEDFAV
GSGTDFTLT
PEDFAVY
PITFGQGTRLEIKRTVAAPSVFIFP
FGQGTRL
FGQGTRLEIKRTVAAPSVFIFPPSDEQ
FGQGTRLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCL
QGTRLEIKRTVA
TRLEIKRTVAAPSVFIFPPSDEQLK
TRLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFY
APSVFIFP
APSVFIFPPSDEQLKSGTASVVCLL
FPPSDEQLKSG
SDEQLKSGTASVVCLLNNFY
TASVVCLLNNFYPREAKVQW
VCLLNNFYPREAKVQWKVDNALQSGNSQES
FYPREAKVQWKVDNALQSG
FYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTY
REAKVQW
QWKVDNALQSGNSQESVTEQDSKDSTYSLSST
WKVDNALQSGNSQESVT
VDNALQSGNSQESVTEQDSKDST
SGNSQESVTEQDSKDSTYSLSSTLTLSKADYEK
SGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYA
NSQESVTEQDSKDSTYSLSSTLTLSKAD
QESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEV
SVTEQDSKDSTYSLSSTL
VTEQDSKDSTYSLSSTLTLSK
VTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQG
TEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQG
EQDSKDSTYSL
EQDSKDSTYSLSSTLTLS
DSKDSTYSLSS
DSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPV
SKDSTYSLSSTLTLSK
LSSTLTLSKADYEKHKVYACEVTHQ
LTLSKADYEKHK
TLSKADYEKHKVYA
ADYEKHKVYACEVTHQGLSSPV
HKVYACEVTHQGLSSPVTKSFNR
CEVTHQGLSSPVTKSFN
EVTHQGLS
EVTHQGLSSPVT
GLSSPVTKSFNRGEC
# Generated sample - 10106L|ascrinvacumab|Homo sapiens||L-KAPPA (V-KAPPA (1-108) [D1] + C-KAPPA (109-215) [D2])|||||||215|215|||MW undefined|MW undefined| - Alfalytic protease - 50%
WYQQKPGQA
GIPDRFS
RLEPEDFA
FNRGEC
# Generated sample - 10425H|brazikumab|Homo sapiens||H-GAMMA-2 (VH (1-124) [D1] + CH1 (125-222) [D2] + CH2 (235-343) [D3] + CH3 (344-448) [D4])|||||||450|450|||MW undefined|MW undefined| - Trypsin - 50%
NTLYLQMNSLR
AEDTAVYYCAR
GYTSSWYPDAFDIWGQGTMVTVSSASTK
GPSVFPLAPCSR
STSESTAALGCLVK
CCVECPPCPAPPVAGPSVFLFPPKPK
TPEVTCVVVDVSHEDPEVQFNWYVDGVEVHNAK
EEQFNSTFR
GLPAPIEK
TTPPMLDSDGSFFLYSK
WQQGNVFSCSVMHEALHNHYTQK
# Generated sample - 10425H|brazikumab|Homo sapiens||H-GAMMA-2 (VH (1-124) [D1] + CH1 (125-222) [D2] + CH2 (235-343) [D3] + CH3 (344-448) [D4])|||||||450|450|||MW undefined|MW undefined| - Chymotrypsin - 50%
VESGGGVVQPGRSL
SCAASGF
DGSNEY
RAEDTAVY
CARDRGY
TSGVHTF
SSVVTVPSSNF
TCNVDHKPSNTKVDKTVERKCCVECPPCPAPPVAGPSVF
PPKPKDTL
ISRTPEVTCVVVDVSHEDPEVQF
VDGVEVHNAKTKPREEQF
TVVHQDW
PAPIEKTISKTKGQPREPQVY
PPSREEM
KTTPPM
DSDGSF
QQGNVF
# Generated sample - 10425H|brazikumab|Homo sapiens||H-GAMMA-2 (VH (1-124) [D1] + CH1 (125-222) [D2] + CH2 (235-343) [D3] + CH3 (344-448) [D4])|||||||450|450|||MW undefined|MW undefined| - LysC - 50%
GLEWVAVIWYDGSNEYYADSVK
GRFTISRDNSK
GPSVFPLAPCSRSTSESTAALGCLVK
CCVECPPCPAPPVAGPSVFLFPPK
PREEQFNSTFRVVSVLTVVHQDWLNGK
GLPAPIEK
GFYPSDIAVEWESNGQPENNYK
SLSLSPGK
# Generated sample - 10425H|brazikumab|Homo sapiens||H-GAMMA-2 (VH (1-124) [D1] + CH1 (125-222) [D2] + CH2 (235-343) [D3] + CH3 (344-448) [D4])|||||||450|450|||MW undefined|MW undefined| - Aspecific - 50%
QLVESGGGVVQPGRSLRLSCAASGFTFSSYG
GGVVQPGRSLRLSCAASGFTFSSYGM
VQPGRSLRLSCAASGFTFSSYGMH
VQPGRSLRLSCAASGFTFSSYGMHWV
VQPGRSLRLSCAASGFTFSSYGMHWVRQAP
SLRLSCAASGFTFSSYGMHWVRQA
LSCAASGFTFSSYGMHW
ASGFTFSSYGMHWVRQAPGKGL
GFTFSSYGMHWVRQAPGKGLEWVAVIWYDGSNEY
TFSSYGM
GMHWVRQAPGKGLEWVAVIWYDGSNEYY
HWVRQAPGKGLEWVAVI
WVRQAPGKGLEWVAVIWYDGSNEYYADSVKG
VRQAPGKGLEWVAVIWYDGSNEYYA
VRQAPGKGLEWVAVIWYDGSNEYYADSVKGRFTISR
LEWVAVIWYDGSNEYYADSVKGRFTISRDNSKNTL
WVAVIWYDGSNEYYADSVK
AVIWYDGSN
IWYDGSNEYYADS
YDGSNEYYADSVKGRFTISRDNSKNTLYLQMNS
GSNEYYADSVKGRFTISRDNSKNTLYLQMNSLR
SNEYYADSV
EYYADSVKG
ADSVKGRFTISRDNSKNTLYLQM
SVKGRFTISRDN
GRFTISRDNSKNTLYLQMNSLRAEDTAV
TISRDNSKNTLYLQMNSLRAEDTAVYY
SKNTLYLQMNSLRAEDTAVYYCARDRGYTSSWYPDAFDIW
YLQMNSLRAEDTAVYY
LQMNSLR
LQMNSLRAEDTAV
SLRAEDTAVYYCARDRG
ARDRGYTSSWYPDAFDIWGQGTMVTVSSAS
DRGYTSSWYPDAFD
GYTSSWYPDAFDIWGQGTMVTVSSASTKGPSVFPLAPC
WYPDAFDIWGQGTMVTVSSASTKGPSV
YPDAFDIWGQ
DAFDIWGQGTMVTVSSASTKGPSVFPLAP
FDIWGQGTMVTVSSASTKGPSVFPLAPCSRSTSESTAAL
DIWGQGT
IWGQGTMVTVSSASTKGPSVFPLAPCSRSTSESTA
MVTVSSASTKGPSVFPLAPCSRSTSESTAALG
TVSSASTKGPSVFPLAPCSRSTSE
TVSSASTKGPSVFPLAPCSRSTSESTA
KGPSVFPLA
VFPLAPCSRSTSES
LAPCSRSTSESTAAL
PCSRSTSESTAALGCLV
CSRSTSESTAALGCLVKDYFP
SRSTSESTAALGCLVKDYFP
SRSTSESTAALGCLVKDYFPEPVT
STAALGCLV
GCLVKDYFPEPVT
CLVKDYFPEPVTVSWNSGALTSGVHTFP
PVTVSWNSGALTSGVH
TVSWNSGALTSGV
TVSWNSGALTSGVHTFPAV
TVSWNSGALTSGVHTFPAVLQS
TVSWNSGALTSGVHTFPAVLQSSG
VSWNSGALTSGVHTFPAVLQSSGLYSLSSVVT
NSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSNF
NSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSNFGTQ
ALTSGVHT
TFPAVLQ
FPAVLQSSGLYSLSSVVTVPSSNFGTQTYTCNVDHKPSNT
VLQSSGLYSLSSVVTVPSSN
VLQSSGLYSLSSVVTVPSSNFGTQTYTCNVDHKPS
SSGLYSLSS
SLSSVVTVPSSNFGTQTYTCNVDHKPSNTKVDKTVE
VTVPSSNFGTQ
PSSNFGTQT
SSNFGTQTYTC
TYTCNVDHKPSNTKVDKTVERKCCVECPPCPAP
CNVDHKPSNTKVDKTVERKCCVECPPCPAPPVAGPSVFLF
DHKPSNTKVDKTVERKCCVECPPC
DKTVERKCCVECPPCPAPPVAGPSVFLFPPKPKDTLM
KTVERKCC
RKCCVECPPCPAPPVAGPSVF
RKCCVECPPCPAPPVAGPSVFLFP
CVECPPCPAPPVAGPSVFLFPPKPKDTLMISRTPEVTC
ECPPCPAPPVAGPSVFLFPPKP
ECPPCPAPPVAGPSVFLFPPKPKDTLMISRTPEV
PPCPAPPVAGPSVFLFPPKPKDTLM
PCPAPPVAGPSVFL
APPVAGPSVFLFPPK
PPVAGPSVFLFPPKPKDTLMISR
VFLFPPKPKDTLMI
KDTLMISRT
MISRTPEVTCV
ISRTPEVTCVVVDVSHEDPEVQFNWYVDGV
EVTCVVVDVSHEDPEVQFNWYVDGVEVHNA
CVVVDVSHEDPEVQFNWYVDGVEVHNAKTKPRE
HEDPEVQFNWYVDGVEVHNAKTK
DPEVQFNW
PEVQFNWYV
VDGVEVHNAKTKPREEQFNSTFRVV
VDGVEVHNAKTKPREEQFNSTFRVVSVLTVV
GVEVHNAKTKP
EVHNAKTKPREEQFNSTFRVV
VHNAKTKPREEQ
KTKPREEQFNSTFRVVSV
REEQFNS
RVVSVLTVVHQDWLNGKEYKCKVSNKGLPAPI
HQDWLNGKEYKCKVSNKGLPAPIEK
HQDWLNGKEYKCKVSNKGLPAPIEKT
QDWLNGKEYKCKVSNKGLP
NGKEYKCKVSNKGLPAPIEK
EYKCKVSNKGLPAPIEKTISKTKGQPREPQVY
YKCKVSNKG
KVSNKGL
KVSNKGLPAPIEKTISKTKGQ
LPAPIEKTISKTKG
LPAPIEKTISKTKGQPREPQVYTLPPSREE
PIEKTISKTK
ISKTKGQPREPQVYTLPPSREEMTKNQV
TKGQPREPQVYTLPP
KGQPREPQVYTLPPSREEMTKNQ
GQPREPQVYTLPPSREEMTKNQVSLTC
TLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPE
LPPSREEMTKNQVSLTCLVKGFYP
PPSREEMTKNQVSLTCLVKGFYPS
REEMTKNQVSLTCLVKGFYPSDIAV
MTKNQVSLTCLVKGFY
MTKNQVSLTCLVKGFYPS
QVSLTCLVKGFYP
QVSLTCLVKGFYPSDIAVEWE
LTCLVKGFYPSDIAVEWES
LTCLVKGFYPSDIAVEWESNGQPENNYKTTPPMLDSDGS
GFYPSDIAVEWESNG
FYPSDIAVEWESN
PSDIAVEW
DIAVEWESNGQPENNYKTTPPML
PENNYKTTPPMLDSDGSFFLYSKLTVDK
NNYKTTPPMLDSDGSFFLYSKLTVD
NNYKTTPPMLDSDGSFFLYSKLTVDKSRWQQGNVFSC
YKTTPPMLDSDGSFFLYSKLTVDKSRWQQGNV
GSFFLYSKLTVDKSRWQQGNVFSCSV
SKLTVDKSR
GNVFSCSVMH
GNVFSCSVMHEALHN
CSVMHEA
MHEALHNHY
# Generated sample - 10425H|brazikumab|Homo sapiens||H-GAMMA-2 (VH (1-124) [D1] + CH1 (125-222) [D2] + CH2 (235-343) [D3] + CH3 (344-448) [D4])|||||||450|450|||MW undefined|MW undefined| - Alfalytic protease - 50%
PGKGLEWV
IWYDGS
RDRGYT
FDIWGQGT
KDYFPEPV
ERKCCV
FLFPPKPKDT
HEDPEV
KPREEQFNS
HQDWLNGKEYKCKV
NKGLPA
KGQPREPQV
PPMLDS
# Generated sample - 10425L|brazikumab|Homo sapiens||L-LAMBDA (V-LAMBDA (1-111) [D1] + C-LAMBDA (112-217) [D2])|||||||217|217|||MW undefined|MW undefined| - Trypsin - 50%
QSVLTQPPSVSGAPGQR
LLIYGSGNRPSGVPDR
LTVLGQPK
AAPSVTLFPPSSEELQANK
TVAPTECS
# Generated sample - 10425L|brazikumab|Homo sapiens||L-LAMBDA (V-LAMBDA (1-111) [D1] + C-LAMBDA (112-217) [D2])|||||||217|217|||MW undefined|MW undefined| - Chymotrypsin - 50%
QQVPGTAPKL
GSGNRPSGVPDRF
QAEDEADY
GGGTRL
GQPKAAPSVTL
PGAVTVAW
KADSSPVKAGVETTTPSKQSNNKY
KSHRSY
SCQVTHEGSTVEKTVAPTECS
# Generated sample - 10425L|brazikumab|Homo sapiens||L-LAMBDA (V-LAMBDA (1-111) [D1] + C-LAMBDA (112-217) [D2])|||||||217|217|||MW undefined|MW undefined| - LysC - 50%
AAPSVTLFPPSSEELQANK
ATLVCLISDFYPGAVTVAWK
ADSSPVK
YAASSYLSLTPEQWK
TVAPTECS
# Generated sample - 10425L|brazikumab|Homo sapiens||L-LAMBDA (V-LAMBDA (1-111) [D1] + C-LAMBDA (112-217) [D2])|||||||217|217|||MW undefined|MW undefined| - Aspecific - 50%
QSVLTQPPSVSGAPGQRVTISCTG
SVLTQPPSVS
TQPPSVSGAPGQRVTISCTGSSSNT
VSGAPGQR
VSGAPGQRVTISCTGSSSNTGAGYDVHWYQQV
QRVTISCTGSSSNTGAGYDVHWY
VTISCTGSSSNTGAGYDVHWYQQVPGTAPKLLIYGSGNRP
CTGSSSNTGAGYD
NTGAGYDVHWYQQVPGTAPKLLIYGSGNRPS
NTGAGYDVHWYQQVPGTAPKLLIYGSGNRPSG
GAGYDVHWYQQVPGTAP
VHWYQQVPGTAPKLLIYGSGNRPS
VHWYQQVPGTAPKLLIYGSGNRPSGVPDRFSGSK
HWYQQVPGTAPKLL
WYQQVPGTAPKL
NRPSGVPDRF
PDRFSGSKSGTSASLAITGLQAEDEADYY
DRFSGSK
DRFSGSKSGTSASLA
SGSKSGT
SGSKSGTSASLAITGLQAEDEADYYCQSYDSSLSGWVFGG
GSKSGTSASLAITGLQAE
GSKSGTSASLAITGLQAEDEADYYCQSYDSSLS
SASLAITGLQAEDEADYYCQSYDSSLSGW
ASLAITGLQAEDEADYYCQSYDSSLSGWVFGGGTRLTVL
AITGLQAEDEA
TGLQAEDEADYYCQSYDSSLSGWVFG
GLQAEDEADYYCQSYDSSLSGW
QAEDEADYYCQSYDSSLSGWVFG
DEADYYCQSYDSSLSGWVFGGGTRLTV
DYYCQSYDSSLSGWVFGGGTRLTVLGQPKAAPSVTLFPP
YCQSYDSSLS
CQSYDSSLSGWVFGGGTRLTVLGQPKAAPSVTLFPPSSE
QSYDSSLSGWVFGG
YDSSLSGWVFGGGTRLTVLGQPKAA
YDSSLSGWVFGGGTRLTVLGQPKAAPSVTLFPPS
GWVFGGGTRLTVLGQPKAAPSV
FGGGTRLTVLGQPKAAPSVTLFPPSSEELQANKATL
GGGTRLTVLGQPKAAPSVTLFPPSSEELQANKATLVCL
GGTRLTVLGQPKAAPSVTLFPPSSEELQANK
GTRLTVLGQPKAAPSVTLFPPSSEE
LGQPKAAPSVTLFPPSSEELQANKATLVCLISDFY
GQPKAAPSVTLFPPSSEELQA
APSVTLFPPSSEELQANKATLVCLISDFYPGAVTVA
VTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSP
PSSEELQANKATLVCLISDFYPGAVTVAWKA
EELQANKATLVCLISD
ELQANKATLVCLISDFYPGAVTVAWK
ANKATLVCLISDFYPGAVTVAWKADSSPVK
NKATLVCLISDFYP
NKATLVCLISDFYPGAVTVAWKADSS
ATLVCLISDFYPGAVTVAW
LISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNN
PGAVTVAWKADSSPVKAGVETTTPSKQ
AVTVAWKADSSPV
SSPVKAGVETTTPSKQSNNKYAASSYLSLT
AGVETTTPSKQ
SKQSNNKYAASSYLSLTPEQWKSHRSYSCQVT
NKYAASSYLSLTPEQWKSHR
KYAASSYLS
YAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPT
AASSYLSLTPEQWKS
AASSYLSLTPEQWKSHRSYSCQVTHEGSTV
SYLSLTPE
EQWKSHRSYSCQVTHEGSTVEKT
SYSCQVTHEGSTVEKTVA
CQVTHEGS
# Generated sample - 10425L|brazikumab|Homo sapiens||L-LAMBDA (V-LAMBDA (1-111) [D1] + C-LAMBDA (112-217) [D2])|||||||217|217|||MW undefined|MW undefined| - Alfalytic protease - 50%
DYYCQS
DFYPGA
# Generated sample - 10296H|erenumab|Homo sapiens||H-GAMMA-2 (VH (1-128) [D1] + CH1 (131-228) [D2] + CH2 (241-349) [D3] + CH3 (350-454) [D4])|||||||456|456|||MW undefined|MW undefined| - Trypsin - 50%
QVQLVESGGGVVQPGR
GLEWVAVISFDGSIK
YSVDSVK
NTLFLQMNSLR
LNYYDSSGYYHYK
YYGMAVWGQGTTVTVSSASTK
DTLMISR
EEQFNSTFR
GLPAPIEK
EPQVYTLPPSR
NQVSLTCLVK
GFYPSDIAVEWESNGQPENNYK
TTPPMLDSDGSFFLYSK
WQQGNVFSCSVMHEALHNHYTQK
# Generated sample - 10296H|erenumab|Homo sapiens||H-GAMMA-2 (VH (1-128) [D1] + CH1 (131-228) [D2] + CH2 (241-349) [D3] + CH3 (350-454) [D4])|||||||456|456|||MW undefined|MW undefined| - Chymotrypsin - 50%
VESGGGVVQPGRSL
VRQAPGKGL
DGSIKY
SVDSVKGRF
TISRDNSKNTL
TSGVHTF
TCNVDHKPSNTKVDKTVERKCCVECPPCPAPPVAGPSVF
PPKPKDTL
VDGVEVHNAKTKPREEQF
KCKVSNKGL
DSDGSF
QQGNVF
# Generated sample - 10296H|erenumab|Homo sapiens||H-GAMMA-2 (VH (1-128) [D1] + CH1 (131-228) [D2] + CH2 (241-349) [D3] + CH3 (350-454) [D4])|||||||456|456|||MW undefined|MW undefined| - LysC - 50%
GRFTISRDNSK
NTLFLQMNSLRAEDTAVYYCARDRLNYYDSSGYYHYK
GPSVFPLAPCSRSTSESTAALGCLVK
CCVECPPCPAPPVAGPSVFLFPPK
NQVSLTCLVK
GFYPSDIAVEWESNGQPENNYK
SRWQQGNVFSCSVMHEALHNHYTQK
# Generated sample - 10296H|erenumab|Homo sapiens||H-GAMMA-2 (VH (1-128) [D1] + CH1 (131-228) [D2] + CH2 (241-349) [D3] + CH3 (350-454) [D4])|||||||456|456|||MW undefined|MW undefined| - Aspecific - 50%
QLVESGGGVVQPGRSLRLSCAASGFTFSS
QLVESGGGVVQPGRSLRLSCAASGFTFSSFGMHWVRQAPG
GVVQPGRSLRLSCAASGFTFSSFGMHWVRQAPGKGLE
GVVQPGRSLRLSCAASGFTFSSFGMHWVRQAPGKGLEW
VVQPGRSLRLSCAASGFTFSSFGMHWVRQAPGK
VQPGRSLRLSCAASGFTFS
QPGRSLRLSCAASGFTFSSFGMHWVRQAPGK
PGRSLRLSCAASG
RSLRLSCA
RSLRLSCAASGFTFSSFGMHWVRQAP
SCAASGFTF
SGFTFSSF
GFTFSSFGMHWVRQAPGKGLEWVAVISFDGSIKYSVDSV
FSSFGMHWVRQAPGKGLEWVAV
VRQAPGK
QAPGKGLEWVAVISFDGSIKYSVDSVKGRFTISRD
PGKGLEWVAVISFDGSIKYSVDSVKGRFTISRDNSKNTLF
KGLEWVAVISFDGSIKYSVDS
EWVAVISFDGSIKYSVDSVKGRFTISR
WVAVISFDGSIKYSVDSVKGRFTISRDNSKNTL
AVISFDGSIKYSVDSVKGRFTISRD
ISFDGSIKYSVDSVKGRFTISRDN
DGSIKYSVDSVKGRFTISRDNSKNTLFLQMN
KYSVDSVKGRFTISRD
KYSVDSVKGRFTISRDNSKNTLFL
SVDSVKGRFTISRDNSKNTLF
SVDSVKGRFTISRDNSKNTLFLQMNSLRAEDTAVYY
VKGRFTISRDNSKNTLFLQMNSLRAEDTAVYYCARDRLNY
KGRFTISRDNSKNTL
KGRFTISRDNSKNTLFLQMNSLRAE
KGRFTISRDNSKNTLFLQMNSLRAEDT
GRFTISRDNSKNTLFLQMNSLRAEDTAVYYCARDRLNY
TISRDNSKNTLFLQMNSLRAEDTAVYYCARDR
NSKNTLFLQMNSLRAEDTAVYYCARDRLNYYDSSGY
SKNTLFLQMNSLRAEDTA
KNTLFLQMNSLRAED
NSLRAEDTA
AEDTAVYYCAR
EDTAVYYCARDRLNYYDSSGYYHYKYYGMAVWGQGT
DTAVYYCAR
YCARDRLNYYDSSGYYHYKYYGMAVWGQGTTVT
ARDRLNYYDSSGYYHYKYYGMAVWGQGT
DRLNYYDSSGYYHYKYY
DSSGYYHYKYYGMAVWGQGTTVTVS
GYYHYKYYGMAVWGQGTTVTVSSASTKGPSVFPL
YYHYKYYGMAVWGQGTTVTVSSASTK
YHYKYYGMAVWGQGTTVTVSSASTKGPSVFPLAPCSRSTS
TTVTVSSASTKGPSVFPLAPCSRSTSESTAALGC
VTVSSASTKGPSV
STKGPSVFPLAPCSRSTSE
STKGPSVFPLAPCSRSTSESTAALGCLV
SVFPLAPCSRSTSESTAALGCLVKDYF
CSRSTSESTAALGCLVKDYFPEPVTVSWNSG
AALGCLVKDYFPEPVTV
GCLVKDYFPEPVTVSWNSGALTSGVHTFPAV
CLVKDYFPEPVTVS
DYFPEPVTVSWNSGALTSG
YFPEPVTVSWNS
EPVTVSWNSGALTSGVHTFPAVLQS
SWNSGALTSGVHTFPAVLQSSGLY
TSGVHTFPAVLQSSGLYSLSSV
HTFPAVLQSSGLYS
TFPAVLQSS
SSGLYSLSSVVTVPSSNFGTQTYT
YSLSSVVTVPSSNFGTQT
YSLSSVVTVPSSNFGTQTYTCNVDHKPSNTKVD
GTQTYTCNVDHKPSNTKVDKTVERKCCVECPPCPAPPVAG
DHKPSNTKVDKTVERKCCVE
DKTVERKCCVECPPCPAPPVAGPSVFLFP
ERKCCVECPPC
RKCCVECPPCPAPPVAGPSVFLFPP
CCVECPP
CVECPPCPAPPVA
PPCPAPPVAGPSVFLF
CPAPPVAGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSH
VFLFPPKPKDTLMISRTPE
ISRTPEVT
PEVTCVVVDVSHEDP
VTCVVVDVSHEDPEVQFNWYVDGVEVHNAKT
TCVVVDVSHEDPEVQFNWYVDGVEV
VVVDVSHED
VSHEDPEV
PEVQFNWYVDGVEVHNAKT
VQFNWYVDG
QFNWYVDGVEVH
YVDGVEVHNAKT
DGVEVHNAKTKPREEQFNSTFRVVSVL
VEVHNAKTKPREEQFNSTFRVVSVLTVVH
EVHNAKTKPREEQFNSTF
NAKTKPREEQFNSTFRVVSVLTVVHQDW
NAKTKPREEQFNSTFRVVSVLTVVHQDWLNGKE
KTKPREEQFNSTFRVVSVLTVVHQDWLNGKEYKCKVSN
TKPREEQFNSTF
PREEQFNSTFRVVSVLTVVHQDWLNGKEYKC
PREEQFNSTFRVVSVLTVVHQDWLNGKEYKCKVSNKGL
EEQFNSTFRVVSV
EQFNSTFRVVSVLTVVHQDWLNGKEYKCKVSN
NSTFRVVSV
STFRVVSVLTVVHQDWLNGKEYKCKVSNK
FRVVSVLTVVHQDWLNGKEYKCKVSNKGLPA
VSVLTVVH
VLTVVHQDWLNGKEYKCKVSNKGLPAPIEKTISK
HQDWLNGKEYKCKVSNKGLPAPIEKTISKTKGQPREPQVY
QDWLNGKEYKCKVSNKGLPAPIE
CKVSNKGLPAPIEKTISKTKGQP
VSNKGLPAPIEKTISKTKGQPREPQVYTLPPSREE
SNKGLPAPIEKTISKTKGQPREPQ
EKTISKTKG
TISKTKGQPREPQV
KTKGQPREPQVYTLPPSREEMTKNQVSLTC
KTKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFY
QVYTLPPSREEMT
YTLPPSREEMTKNQVSLTCLVKGFYPSDI
TLPPSREEMT
PSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPEN
REEMTKNQVSLTCLVKGFYPSDIAVEW
EEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNY
EEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTP
TKNQVSLTC
NQVSLTCLVKG
NQVSLTCLVKGFYPSDI
VSLTCLVKGFYPSDIAVEWES
VKGFYPSDIAVEWESNGQPENNYKT
EWESNGQPE
NNYKTTPPMLDSDGSFFLYSKLTVDKSRWQQGNVFSC
NYKTTPPMLDSDGSFFLYSK
DGSFFLYSKLTVDKS
SFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQ
FLYSKLTVDKSRWQQGNVFSCSVMHEA
LYSKLTVDKSRWQQGNVFSCSVMHEALHN
YSKLTVDKSRWQQGNVF
TVDKSRWQQGNVFSCSVMHEAL
QQGNVFSCSVMHEALHN
VFSCSVMHEALHNH
VFSCSVMHEALHNHYTQ
# Generated sample - 10296H|erenumab|Homo sapiens||H-GAMMA-2 (VH (1-128) [D1] + CH1 (131-228) [D2] + CH2 (241-349) [D3] + CH3 (350-454) [D4])|||||||456|456|||MW undefined|MW undefined| - Alfalytic protease - 50%
FGMHWV
LFLQMNS
RDRLNYYDS
KDYFPEPV
ERKCCV
FLFPPKPKDT
KPREEQFNS
NKGLPA
KGQPREPQV
PPMLDS
# Generated sample - 10296L|erenumab|Homo sapiens||L-LAMBDA (V-LAMBDA (1-110) [D1] + C-LAMBDA (111-216) [D2])|||||||216|216|||MW undefined|MW undefined| - Trypsin - 50%
VTISCSGSSSNIGNNYVSWYQQLPGTAPK
RPSGIPDR
LSAVVFGGGTK
ATLVCLISDFYPGAVTVAWK
ADGSPVK
YAASSYLSLTPEQWK
SYSCQVTHEGSTVEK
TVAPTECS
# Generated sample - 10296L|erenumab|Homo sapiens||L-LAMBDA (V-LAMBDA (1-110) [D1] + C-LAMBDA (111-216) [D2])|||||||216|216|||MW undefined|MW undefined| - Chymotrypsin - 50%
TQPPSVSAAPGQKVTISCSGSSSNIGNNY
PGTAPKL
DNNKRPSGIPDRF
SGSKSGTSTTL
GQPKANPTVTL
PPSSEEL
QANKATL
PGAVTVAW
# Generated sample - 10296L|erenumab|Homo sapiens||L-LAMBDA (V-LAMBDA (1-110) [D1] + C-LAMBDA (111-216) [D2])|||||||216|216|||MW undefined|MW undefined| - LysC - 50%
LLIYDNNK
RPSGIPDRFSGSK
SGTSTTLGITGLQTGDEADYYCGTWDSRLSAVVFGGGTK
ATLVCLISDFYPGAVTVAWK
TVAPTECS
# Generated sample - 10296L|erenumab|Homo sapiens||L-LAMBDA (V-LAMBDA (1-110) [D1] + C-LAMBDA (111-216) [D2])|||||||216|216|||MW undefined|MW undefined| - Aspecific - 50%
QPPSVSAAPGQKVTISCSGSSSNIGNN
PSVSAAP
PSVSAAPGQKVT
APGQKVTISCSGSSSNIGNNYVSWYQQLP
QKVTISCSGSSSNIGNNYVSWYQQLPGTAPKLLIYDNN
QKVTISCSGSSSNIGNNYVSWYQQLPGTAPKLLIYDNNK
SGSSSNIGNNYVSWYQQLPGTAPKLLIYDNNKR
SSSNIGNNYVSWYQQLPGTAPKLLIYDNNKRPS
SSNIGNNYVSWYQQLPGTAPKLLIYDN
NIGNNYVSWYQQLPGTAPKLLIYDNNKR
GNNYVSW
WYQQLPG
LPGTAPKLLIYDNNKRPSGIPD
GTAPKLLIYDNNKRPSGIPDRFSGSKSGTSTTLGITGL
KLLIYDNNKRPSGIPDRFSGSKSGTSTTLG
NKRPSGIP
NKRPSGIPDRFSGSKSGTSTTLGITGLQTGD
NKRPSGIPDRFSGSKSGTSTTLGITGLQTGDEADY
PSGIPDRFSGSKSGTS
GIPDRFSGSKSGTSTTLG
PDRFSGSKSGTSTTLGITGLQ
PDRFSGSKSGTSTTLGITGLQTG
PDRFSGSKSGTSTTLGITGLQTGDEADYYCGTWDSR
DRFSGSKSGTSTTLGIT
RFSGSKSGTSTTLGITGLQTGDEAD
FSGSKSGTSTTLGITGLQTGDEADYYCGTWDSRLS
SGSKSGT
SKSGTSTTLGITGLQTGDEADYYCGTWDSRLSAVVFGGG
KSGTSTTLGITGLQTGDEADYYCGTWDSRLSAVVFGGG
GTSTTLGITGLQTGDEADYYCG
TSTTLGITGLQTGDEADYYCGTWDSRLSA
TSTTLGITGLQTGDEADYYCGTWDSRLSAVVFGGGTKL
GITGLQTGDEADYYCG
ITGLQTGDEADYYCGTW
GLQTGDEADYYCGTWDSRLSAVVFGGGTKLTVLGQPKAN
EADYYCGTWDSRLSAVVFGGGT
DYYCGTWDSRLSAVVF
CGTWDSRLSAVVFGGGTKLTVLGQPKANPTVTLFP
SRLSAVVFGGGTKLTVLGQPKANPTVTL
VFGGGTKLTVLGQPKANPTVTLFPPSS
TKLTVLGQPKANPTVTLFPPSSEELQANK
KLTVLGQPKANPTVTLFPPS
QPKANPTVTL
PKANPTVTLFPPSSEELQANKATLVCL
ANPTVTLFPPSSEELQANKATLVCLISDFY
NPTVTLFPPSSEELQANKATLVCLISD
PTVTLFPPSSEELQA
PSSEELQANKATLVCLISDFYPGAVTVA
SEELQANKATLVCLISDFYPGAVTVAWKAD
TLVCLISDFYPGAVTVAWKADGSPV
CLISDFYPGAVTVAW
CLISDFYPGAVTVAWKADGSPVKAGVE
LISDFYP
LISDFYPG
FYPGAVTVA
PGAVTVAWKADGSPVKAGVETTKPSKQSNNK
VTVAWKADGSPVKAGVETTKPSKQSNNKYAASSYLSLTPE
VAWKADGSPVKAGVE
AWKADGSPVKAGVETTKPSKQSN
SPVKAGVETTKPSKQSNNKYAASSYLSLTPEQWK
ETTKPSKQSN
ETTKPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEG
KPSKQSNNKYAASSYLSLTPEQW
PSKQSNNKYAASSYLSLTPEQWKSH
SKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGST
KQSNNKYAASSYLSLTP
AASSYLSLTPEQWKSHRSYSCQVT
ASSYLSLTPEQWK
ASSYLSLTPEQWKSHRSYSCQVTHEGSTVE
QWKSHRSYSCQV
HRSYSCQVTHEGSTVEKTVAPTEC
# Generated sample - 10296L|erenumab|Homo sapiens||L-LAMBDA (V-LAMBDA (1-110) [D1] + C-LAMBDA (111-216) [D2])|||||||216|216|||MW undefined|MW undefined| - Alfalytic protease - 50%
NIGNNYV
LGQPKA
PEQWKS
# Generated sample - 9336H|atinumab|Homo sapiens||H-GAMMA-4 (VH (1-114) [D1] + CH1 (115-212) [D2] + CH2 (225-334) [D3] + CH3 (335-439) [D4])|||||||441|441|||MW undefined|MW undefined| - Trypsin - 50%
LSCAASGFTFSNYWMSWVR
GLEWVATIK
TPEVTCVVVDVSQEDPEVQFNWYVDGVEVHNAK
VVSVLTVLHQDWLNGK
GLPSSIEK
EPQVYTLPPSQEEMTK
NQVSLTCLVK
GFYPSDIAVEWESNGQPENNYK
TTPPVLDSDGSFFLYSR
WQEGNVFSCSVMHEALHNHYTQK
# Generated sample - 9336H|atinumab|Homo sapiens||H-GAMMA-4 (VH (1-114) [D1] + CH1 (115-212) [D2] + CH2 (225-334) [D3] + CH3 (335-439) [D4])|||||||441|441|||MW undefined|MW undefined| - Chymotrypsin - 50%
VATIKQDGSQKNY
VTVSSASTKGPSVF
PEPVTVSW
SSVVTVPSSSL
GPPCPSCPAPEF
PPKPKDTL
RVVSVL
KCKVSNKGL
PSSIEKTISKAKGQPREPQVY
PSDIAVEW
ESNGQPENNY
DSDGSF
TVDKSRW
QEGNVF
# Generated sample - 9336H|atinumab|Homo sapiens||H-GAMMA-4 (VH (1-114) [D1] + CH1 (115-212) [D2] + CH2 (225-334) [D3] + CH3 (335-439) [D4])|||||||441|441|||MW undefined|MW undefined| - LysC - 50%
GLEWVATIK
QDGSQK
NYVDSVK
GRFTISRDNAK
GPSVFPLAPCSRSTSESTAALGCLVK
GLPSSIEK
GQPREPQVYTLPPSQEEMTK
NQVSLTCLVK
GFYPSDIAVEWESNGQPENNYK
SRWQEGNVFSCSVMHEALHNHYTQK
# Generated sample - 9336H|atinumab|Homo sapiens||H-GAMMA-4 (VH (1-114) [D1] + CH1 (115-212) [D2] + CH2 (225-334) [D3] + CH3 (335-439) [D4])|||||||441|441|||MW undefined|MW undefined| - Aspecific - 50%
GGLVQPGGSLRLSCAASGFTFSNYWM
GLVQPGGS
GLVQPGGSLRLSCAASGFTFSNYWMSWVRQ
LVQPGGSLRLSCAASGF
LVQPGGSLRLSCAASGFTFSNYWMSWVRQA
VQPGGSLRLSCAASGFT
QPGGSLRLSCAASGFTF
PGGSLRLSCAASGFTFSNYWMSWVR
PGGSLRLSCAASGFTFSNYWMSWVRQAPGKGLEW
GGSLRLSCAASGFTFSNYWMSWVRQAPGKGLEWVATIKQ
CAASGFTFS
FTFSNYWMSWVRQAPGKGLEWVATIKQDGSQKNYVDSV
FSNYWMSW
FSNYWMSWVRQAPGKGLEWVATIKQDGSQKNYVD
FSNYWMSWVRQAPGKGLEWVATIKQDGSQKNYVDSVKGRF
WMSWVRQAPGKGLEWVATIKQDGSQKNYVDS
MSWVRQAPGKGLEWVATIKQ
MSWVRQAPGKGLEWVATIKQDG
GLEWVATIKQDGSQKNYVDSVKGR
EWVATIKQDGSQKNYVDSVKGRF
TIKQDGSQKNYVDSVKGRFT
IKQDGSQKNYVDSVKGRFTI
DGSQKNYVDSVKGRFTISRDNAKNSLYLRLNSLRA
QKNYVDSVKGRFTISRD
QKNYVDSVKGRFTISRDNAKNSLYLRLNSLRAEDTAV
DSVKGRFTISRDNAKNSLYLRLNSLRAE
KGRFTISRDNA
RFTISRDNAKNSLYLRLNSLRAE
TISRDNAKN
ISRDNAKNSLYLRLNSLRAEDTAVYYCATELFDLWGRG
RDNAKNSLYLRLNSLRAED
AKNSLYLRLNSLRAEDTAVYYCATELFDLW
LRLNSLRAEDTAVYYCATELFDLWGRGSLVTVSSASTKGP
SLRAEDTAVYYCATELFDLWGRGSLVTVSSASTK
YCATELFDLWG
ATELFDLWGRGSLVTV
FDLWGRGSL
FDLWGRGSLVT
RGSLVTV
GSLVTVSSASTKGPSVFPLAPC
SLVTVSSASTKGPSVF
TVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEP
TSESTAALGCLVKDYFPEPVT
LGCLVKDYFPEPVTVSWN
LVKDYFPEPVTVS
VKDYFPEPVTVSWNSGALTSG
YFPEPVT
EPVTVSWNSGALTSGVHTFP
VTVSWNSGALTSGVHTFPAVLQSSG
SGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGT
SGVHTFPAVLQSSGLYSLSSVVTV
VHTFPAVL
TFPAVLQSSGLYSLSSVVT
PAVLQSSGLYSLSSVVTVPSSSLGTKTYTCNV
AVLQSSGLYSLSSVVTVPSSSLGTKTYTCNVDHKPSN
LSSVVTVPSSSLGTKTYTCNVDHKPSNT
LSSVVTVPSSSLGTKTYTCNVDHKPSNTKVDKRVESKYGP
SSVVTVPSSSLGTKTYTCNVDHKPS
VTVPSSSLGTKTYTC
VPSSSLGTKTYTCNVDHKPSNTKVDKRVESKYGP
SSSLGTKTYTCNVDHKPSN
SSLGTKTYTCNVDHKPSNTKVDKRVESKYG
TKTYTCNVDHKPSNT
TYTCNVD
YTCNVDHKPSNTKVDKRVESKYGPPCPSCPAPEF
NVDHKPSNTKVDKRVE
DHKPSNTKVDKRV
KVDKRVESKYGPPCPSCPAPEFLGGPSVFL
KRVESKYGPPCPSCPAPEFLGGPSVF
RVESKYGPPCPSCPAPEFLGGPSVFLFPPKPKDTLM
KYGPPCPSCPAPEFLGG
YGPPCPSCPAPEFLGGPSVFLFPPKPKDTLMISRTPEVTC
PCPSCPAPEFLGGPSVFLFPPKPKDTLMISRTPEVTCV
CPSCPAPEFLGGP
CPAPEFLGGPSVFLFPPKPKDTLMISRTPEVTCVVV
APEFLGGPSVF
APEFLGGPSVFLF
APEFLGGPSVFLFPPKPKDTLMISRTPEVTC
FLGGPSVFLFPPKPKDTLMISRTPEVTCVVV
FLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDV
VFLFPPKPKDTLMISRTPEVTCVVVDVSQE
VFLFPPKPKDTLMISRTPEVTCVVVDVSQEDPEVQ
FLFPPKPKDTLMISRTPEVTCVVVDVSQEDPEVQFNW
KPKDTLMISRTPEV
KDTLMISRTPEVTCVVVDVSQEDPEVQFNW
DTLMISRTPEV
LMISRTPEVTCVVV
LMISRTPEVTCVVVDVSQEDPEVQFNWYVD
MISRTPEVTCVVVDVSQEDPEVQFNWYVDG
ISRTPEVTCVVVDVSQEDPEV
ISRTPEVTCVVVDVSQEDPEVQ
VTCVVVDVSQEDPEVQFNWYVDGVEVHNAKTKPREEQ
TCVVVDVSQE
TCVVVDVSQEDPEVQFN
TCVVVDVSQEDPEVQFNWYVDGVEVHNAKTKP
VVDVSQEDPEVQ
SQEDPEVQFNWYVDGVEVHN
DPEVQFNWYVDGVEVH
QFNWYVDGVEVHNAKTKPREEQFNSTYRVVS
FNWYVDGVEVHNAKTKPREEQFNSTYRV
NWYVDGVE
WYVDGVEVHNAKTKPREEQFNSTY
VEVHNAKTKPRE
KTKPREEQFNSTYRVVSVLTVLHQDWLNGKEYKCK
TKPREEQFNSTYRVVSVLTVLHQD
VVSVLTVLHQD
VLTVLHQDWLNGKEYKCKVSNKGLPSSIEKTISKAKGQ
HQDWLNGKEYKCKVSNKGLPSSIEK
WLNGKEYKCKVSNKGLPSSIEKTISKAKGQPREPQVYT
KEYKCKVSNKGL
KCKVSNKGLPSSIEKTISKAKGQPR
VSNKGLPSSIEKTISKAKGQPREPQVYTLPPSQEEMTK
SNKGLPSSIEKTISKAKGQPREPQVYTLP
KGLPSSIEKTISKAKGQPREPQVYT
SSIEKTISKAKGQPREPQVYTLP
SIEKTISKAKGQPREPQVYTLPPSQEE
TISKAKGQPREPQVYT
SKAKGQPREP
AKGQPREPQVYTLPPS
QPREPQVYTL
EPQVYTLPPSQEEMTKNQVSLTCLVKGFY
YTLPPSQEEMTKNQVSLTCLVKGFY
LPPSQEEMTKNQVS
PSQEEMTKN
SQEEMTKNQVSLTCLVKGFYPS
QEEMTKNQVSLTCLVKGFYPSDIAV
EEMTKNQVSLTCLVKGFYPSDIAVEWE
KNQVSLTCL
SLTCLVKGFYPSDIAVEWESNG
LVKGFYPSDIAVEWESNGQPENNYKTTPPVLDS
GFYPSDIAVEWESNGQPE
DIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSR
ESNGQPENNYKTTPPVLDSDGSFFLYSRLT
SNGQPENNYKTTPPVLDSDGSFFLYSRLTVDKSRWQ
NGQPENNYKTTPPVLDS
NGQPENNYKTTPPVLDSD
GQPENNYKTTPPVLDSDGSF
QPENNYKTTPPVLDSDGSFFLYSRLTVDKSRWQEG
PENNYKTTPPVLDSD
ENNYKTTPPVLDSDGSFFLYSRLTVDKSRWQEGNVFSCSV
NNYKTTPPVLDSDGSFFLYSRLTVDKSRWQEGN
YKTTPPVLDSDGSF
YKTTPPVLDSDGSFFLYSRLTVDKSRWQEGNV
PVLDSDGSFFLYSRLTVDKSRWQEGNVFSCSVMHEA
LDSDGSFFLYSRLTVDK
SDGSFFLYSRLTVDKSRWQEGNVFSCS
FFLYSRLTVDKSRWQEGN
DKSRWQEGNVFSCSVMHE
SRWQEGNVFSCSVMHEALH
GNVFSCSVMHEAL
NVFSCSVMHE
# Generated sample - 9336H|atinumab|Homo sapiens||H-GAMMA-4 (VH (1-114) [D1] + CH1 (115-212) [D2] + CH2 (225-334) [D3] + CH3 (335-439) [D4])|||||||441|441|||MW undefined|MW undefined| - Alfalytic protease - 50%
IKQDGS
ELFDLWGRGS
KYGPPCPS
PEFLGGPS
FLFPPKPKDT
QEDPEV
QFNWYV
KPREEQFNS
LHQDWLNGKEYKCKV
NKGLPS
KGFYPS
RWQEGNV
LHNHYT
# Generated sample - 9336L|atinumab|Homo sapiens||L-KAPPA (V-KAPPA (1-107) [D1] + C-KAPPA (108-214) [D2])|||||||214|214|||MW undefined|MW undefined| - Trypsin - 50%
ASQSVSSYLAWYQQKPGQAPR
LLIYDASNR
FSGSGSGTDFTLTISSLEPEDFAVYYCQQR
SNWPITFGQGTK
VDNALQSGNSQESVTEQDSK
# Generated sample - 9336L|atinumab|Homo sapiens||L-KAPPA (V-KAPPA (1-107) [D1] + C-KAPPA (108-214) [D2])|||||||214|214|||MW undefined|MW undefined| - Chymotrypsin - 50%
TQSPATL
SPGERATL
QQKPGQAPRL
SGSGSGTDF
GQGTKL
KSGTASVVCL
KVDNAL
EKHKVY
# Generated sample - 9336L|atinumab|Homo sapiens||L-KAPPA (V-KAPPA (1-107) [D1] + C-KAPPA (108-214) [D2])|||||||214|214|||MW undefined|MW undefined| - LysC - 50%
RTVAAPSVFIFPPSDEQLK
SGTASVVCLLNNFYPREAK
VDNALQSGNSQESVTEQDSK
VYACEVTHQGLSSPVTK
SFNRGEC
# Generated sample - 9336L|atinumab|Homo sapiens||L-KAPPA (V-KAPPA (1-107) [D1] + C-KAPPA (108-214) [D2])|||||||214|214|||MW undefined|MW undefined| - Aspecific - 50%
VLTQSPATLSLSPGE
SPATLSLSPGERATL
ATLSLSPGER
TLSLSPGERATLSCRASQSVS
TLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPR
SLSPGERATL
SPGERATLS
ERATLSCRA
ASQSVSSYLAWYQQKPGQAPRLLI
QSVSSYLAWYQQKPGQAPRL
SSYLAWYQ
SSYLAWYQQKPGQAPRLLI
WYQQKPGQAPRLLIYDA
WYQQKPGQAPRLLIYDASNRATGIPARFS
YQQKPGQAPRLLIYDASNRATGIPARFS
QKPGQAPRLLIYDASNRATGIPARF
PGQAPRLLIYDASNRATGIPARF
QAPRLLIYDASNRAT
LIYDASNRATGIPARFSG
SGSGSGTD
FTLTISS
FTLTISSLEPEDFAVYYCQQRSNWPITFGQGTKLEIKR
TISSLEPEDFAVYYCQQRSNWPITFGQGTK
DFAVYYCQQRSNWPITFGQGTKLEIKRTVAAPSVFIFP
FAVYYCQQRSN
FAVYYCQQRSNWPITFGQGTKLEIKRTVAAPSVFI
NWPITFGQG
EIKRTVAAPSVFIFPPSDEQLKSG
RTVAAPSVFIFPPSDEQLKSGTASVVCLL
APSVFIFP
FIFPPSDEQLKSGTASVVCLLNNFYP
IFPPSDEQLKS
PPSDEQLKSGTASVV
PSDEQLKSGTASVVCLLNNFYPREA
DEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQS
QLKSGTASVVCLLNNFYPREAKVQWK
SVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKD
VVCLLNNFYP
VCLLNNFYP
CLLNNFYPREAKVQW
LLNNFYPREAKVQWKVDNALQSGNSQESVTEQ
LNNFYPRE
NFYPREAKVQWKVDNALQSGNSQESVTEQD
PREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSS
REAKVQWKVDNALQSGNSQESVTE
EAKVQWKVDNAL
KVDNALQSGNSQESVTEQDSKDST
SVTEQDSKDSTYSLSSTLTLSKADYEKHK
QDSKDSTYSLSSTLT
DSKDSTYS
LSSTLTLSKADYEKHKVYACEVTHQGLSSPVTK
SSTLTLSKADYEKHKVYACEVTHQGLS
YEKHKVYA
EVTHQGLSSP
HQGLSSPVTKSFN
QGLSSPVT
# Generated sample - 9336L|atinumab|Homo sapiens||L-KAPPA (V-KAPPA (1-107) [D1] + C-KAPPA (108-214) [D2])|||||||214|214|||MW undefined|MW undefined| - Alfalytic protease - 50%
WYQQKPGQA
PRLLIYDA
LEPEDFA
FIFPPS
DEQLKS
CLLNNFYPREA
DYEKHKV
# Generated sample - 10114H|bleselumab|Homo sapiens||H-GAMMA-4 (VH (1-121) [D1] + CH1 (122-219) [D2] + CH2 (232-341) [D3] + CH3 (342-446) [D4])|||||||448|448|||MW undefined|MW undefined| - Trypsin - 50%
GLEWIGSIYK
NQFSLK
LSSVTAADTAVYYCTRPVVR
YFGWFDPWGQGTLVTVSSASTK
GPSVFPLAPCSR
TYTCNVDHKPSNTK
YGPPCPPCPAPEFEGGPSVFLFPPKPK
TPEVTCVVVDVSQEDPEVQFNWYVDGVEVHNAK
EEQFNSTYR
EPQVYTLPPSQEEMTK
NQVSLTCLVK
TTPPVLDSDGSFFLYSR
# Generated sample - 10114H|bleselumab|Homo sapiens||H-GAMMA-4 (VH (1-121) [D1] + CH1 (122-219) [D2] + CH2 (232-341) [D3] + CH3 (342-446) [D4])|||||||448|448|||MW undefined|MW undefined| - Chymotrypsin - 50%
IRQPPGKGL
KSGSTY
KSRVTISVDTSKNQF
CTRPVVRY
TSGVHTF
EGGPSVF
ISRTPEVTCVVVDVSQEDPEVQF
RVVSVL
KCKVSNKGL
PSSIEKTISKAKGQPREPQVY
PPSQEEM
TKNQVSL
PSDIAVEW
ESNGQPENNY
TVDKSRW
QEGNVF
# Generated sample - 10114H|bleselumab|Homo sapiens||H-GAMMA-4 (VH (1-121) [D1] + CH1 (122-219) [D2] + CH2 (232-341) [D3] + CH3 (342-446) [D4])|||||||448|448|||MW undefined|MW undefined| - LysC - 50%
PSETLSLTCTVSGGSISSPGYYGGWIRQPPGK
SGSTYHNPSLK
NQFSLK
GPSVFPLAPCSRSTSESTAALGCLVK
TYTCNVDHK
YGPPCPPCPAPEFEGGPSVFLFPPK
PREEQFNSTYRVVSVLTVLHQDWLNGK
GFYPSDIAVEWESNGQPENNYK
# Generated sample - 10114H|bleselumab|Homo sapiens||H-GAMMA-4 (VH (1-121) [D1] + CH1 (122-219) [D2] + CH2 (232-341) [D3] + CH3 (342-446) [D4])|||||||448|448|||MW undefined|MW undefined| - Aspecific - 50%
PGLLKPS
KPSETLSLTCTVSG
ETLSLTCTVSGG
SGGSISSPGYYGGWI
SISSPGYYGGWIRQPPGKGLEWIG
ISSPGYYGGWIRQPPGKGLEWIG
SPGYYGGWIRQPPGKGLEWIGSIYKSGST
PGYYGGWIRQPPGKGLEWIGSIYKS
PGYYGGWIRQPPGKGLEWIGSIYKSGSTYHN
YYGGWIRQPPGKGL
YGGWIRQPPG
GGWIRQPPGKGLEWIG
PGKGLEWIGSIYKSGSTYHN
SIYKSGSTYHN
SGSTYHNPSLKSRVTISVDTS
SLKSRVTISVD
VDTSKNQFSLKLSSVTAADTAVYYCTRPVVRYF
KNQFSLKLSSVTAADTAVYY
KNQFSLKLSSVTAADTAVYYCTRPVVRYFGW
QFSLKLSSVTAADTAVYYCTRPVVRY
FSLKLSSVTAADTAVYYCTRPVVRYFGWF
LSSVTAADTAVYYCTRPVVRYFG
SVTAADTAVYYCTRPVVRYFGWFDPW
AVYYCTRPVVRYFGWFDPWGQGT
YCTRPVVRYFGWFDPWGQGTLVTVSSASTKGPSV
CTRPVVRYFGWFD
CTRPVVRYFGWFDPWGQGTLVTVSSASTKGPSVFPL
VRYFGWFDPWGQGTLVTVSSASTKGPSVFPLAPCSR
FGWFDPWGQGTLVTV
FDPWGQGTL
FDPWGQGTLVTVSS
SSASTKGPSVFPLAPCSRSTSESTAA
SSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPE
PSVFPLAPCSRSTSESTAALG
PLAPCSRSTSESTAALGC
LAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSG
PCSRSTS
PCSRSTSESTAALGCLVKDYFPE
TSESTAALGCLVKDYFPEPVTVS
TAALGCLVK
TAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSS
LGCLVKDYFPEPVTVSW
CLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQS
VKDYFPEPVTVSWNSGALTSG
FPEPVTVSWNSGALTSG
FPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSV
ALTSGVHTFPAVLQSSGLYSLSSVVTVPS
VHTFPAVLQSSGLYSLSSVVTVPSSSLGTKTYTCN
VHTFPAVLQSSGLYSLSSVVTVPSSSLGTKTYTCNVDH
PAVLQSSGLYSLSSVVT
AVLQSSGLYS
LYSLSSVVTVPSSSLGTKTYTCNVDHKPSNTKVDKRVESK
LSSVVTVPSSSLGTKTYTCNVDHKPSNTKVDKR
VTVPSSSLGTKTYTCNV
TVPSSSLGTKTYTCNVDHKPSNTKVDKRV
TCNVDHKPSNTK
SNTKVDKRVESKYGPPCPPCPAPEFEGGPSVFLF
NTKVDKRVESKYGPPCPPCPAPEFEGGPSVFLFPPKPKDT
VDKRVESKYGP
YGPPCPPCPAPEFEGGPSVFLFPPKPKDTL
YGPPCPPCPAPEFEGGPSVFLFPPKPKDTLMISRTPEVTC
PPCPAPEFEGGPSVFLFPPKPKDTLM
APEFEGGP
APEFEGGPSVFLFPPKPKDT
GGPSVFLFPPKPKDTLMISRTPEVTCVVVDV
LFPPKPK
LFPPKPKDTLM
LMISRTPEVTCVVVDVS
LMISRTPEVTCVVVDVSQEDPEVQFNWYVDG
ISRTPEVTCVVVDVSQEDPEVQFNWY
SRTPEVTCVVVDVSQEDPEVQFNWYVDGV
SRTPEVTCVVVDVSQEDPEVQFNWYVDGVE
CVVVDVSQEDPEVQFNWYVDGVEVHNAKTKPREEQFNS
VVVDVSQEDPEVQFNWYVDGVEVHNAKTKPREEQF
VVVDVSQEDPEVQFNWYVDGVEVHNAKTKPREEQFNST
DVSQEDPEVQFNWYVDGVEVH
VSQEDPEVQFNWYVDGVEVHNAKTKPREEQFNS
VDGVEVHNAKTKPREEQFNSTYRVVSVLTVLHQDWLN
EVHNAKTKPREEQFNST
KPREEQFNSTYRVVSVLTVLHQDWLNGKEYK
REEQFNSTYRVVSVLT
REEQFNSTYRVVSVLTVLHQ
EQFNSTYRVVSVLTV
QFNSTYRVVSVLTVLHQDWLNGKEYKCKVSNK
STYRVVSVLTVLHQDWLNGKEYK
VSVLTVL
LTVLHQDWLNGKEYKCKVS
TVLHQDW
QDWLNGKEY
WLNGKEYKCKVSNKGLPSSIEKT
GKEYKCKVSNKGLPSSIEK
GKEYKCKVSNKGLPSSIEKTISKAKGQPREPQVYTL
EYKCKVSNKGLPSSIEKTISKAKGQPREPQVYTL
YKCKVSNKGLP
CKVSNKGLPSSIEKTISKAKGQPR
KVSNKGLPSSIEKTISKAKG
GLPSSIEKTISKAKGQPREPQVYTLPP
PSSIEKTISKAKGQPREPQVYTLPPSQEEMTKNQV
PSSIEKTISKAKGQPREPQVYTLPPSQEEMTKNQVSLTC
SIEKTISKAKGQPREPQVYTLPP
EKTISKAKGQPREPQVYTLPPS
EKTISKAKGQPREPQVYTLPPSQEEMTKNQVSLTCLVKG
KTISKAKGQPREPQVYTLPPSQEEMTKN
ISKAKGQPREPQVYTLPPSQE
SKAKGQPREPQVYTLPPSQEEM
SKAKGQPREPQVYTLPPSQEEMTKNQVSLTCL
GQPREPQVYTLPPSQEEMTKNQVSLT
REPQVYTLPPSQEEMTKNQVSLT
QVYTLPPSQE
TLPPSQEEMTKNQVSLTCLVKGF
LPPSQEEM
LPPSQEEMTKNQVSLTCLVKGFYPSD
EEMTKNQVSLTCLVKGFYPSDIA
EMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPP
MTKNQVSLTCLVKGFYPSDIAVEWESNGQPEN
KNQVSLTCLVKGFYPSDIAVEWESNGQPENNYK
FYPSDIAVEWESNGQPENN
IAVEWESNGQPENNYKTTPPV
VEWESNGQPENNYKTTPPVLDSDGSFFLYSRLTVDKSRW
ESNGQPENNYK
GQPENNYKTTPPVLDSDGSFFLYSRLTVDKSRWQ
QPENNYKTTPPVLDSDGSFFLYSRLTVDKSRWQEGNVF
PENNYKTTPPVLDSDGSFFLYSRLTV
KTTPPVLDSDGSFFLYSRLTVDK
TPPVLDSDGSFFLYSRLTVDKSRWQEGNVFSCSV
PVLDSDGSFFLYSRLTVDK
LDSDGSFFLYSRLTVDKSRWQEGNVFSCS
GSFFLYSRLTVDK
SFFLYSRLTVDKSRWQEGNVFSC
LYSRLTVDKSRWQEGNVFSCSVMH
LYSRLTVDKSRWQEGNVFSCSVMHEALHNHYTQKSLS
DKSRWQEGNVFSCSVMHE
EGNVFSCSVMHEAL
VFSCSVMHEALHNHYTQK
VMHEALHNHYTQKSLS
# Generated sample - 10114H|bleselumab|Homo sapiens||H-GAMMA-4 (VH (1-121) [D1] + CH1 (122-219) [D2] + CH2 (232-341) [D3] + CH3 (342-446) [D4])|||||||448|448|||MW undefined|MW undefined| - Alfalytic protease - 50%
QLQLQES
PGYYGGWIRQPPGKGLEWIGS
RYFGWFDPWGQGT
KDYFPEPV
PEFEGGPS
FLFPPKPKDT
QEDPEV
QFNWYV
NKGLPS
KGFYPS
LHNHYT
# Generated sample - 10114L|bleselumab|Homo sapiens||L-KAPPA (V-KAPPA (1-106) [D1] + C-KAPPA (107-213) [D2])|||||||213|213|||MW undefined|MW undefined| - Trypsin - 50%
AIQLTQSPSSLSASVGDR
VTITCR
ASQGISSALAWYQQKPGK
TVAAPSVFIFPPSDEQLK
SGTASVVCLLNNFYPR
VDNALQSGNSQESVTEQDSK
DSTYSLSSTLTLSK
# Generated sample - 10114L|bleselumab|Homo sapiens||L-KAPPA (V-KAPPA (1-106) [D1] + C-KAPPA (107-213) [D2])|||||||213|213|||MW undefined|MW undefined| - Chymotrypsin - 50%
TQSPSSL
SASVGDRVTITCRASQGISSAL
SGSGSGTDF
KSGTASVVCL
PREAKVQW
ACEVTHQGL
# Generated sample - 10114L|bleselumab|Homo sapiens||L-KAPPA (V-KAPPA (1-106) [D1] + C-KAPPA (107-213) [D2])|||||||213|213|||MW undefined|MW undefined| - LysC - 50%
VDNALQSGNSQESVTEQDSK
DSTYSLSSTLTLSK
VYACEVTHQGLSSPVTK
SFNRGEC
# Generated sample - 10114L|bleselumab|Homo sapiens||L-KAPPA (V-KAPPA (1-106) [D1] + C-KAPPA (107-213) [D2])|||||||213|213|||MW undefined|MW undefined| - Aspecific - 50%
LTQSPSSLSASVGDRVTITCRASQGISSALAWYQQKPG
SVGDRVTITCRASQGISSALAWYQQKPGKAPKLLIYDAS
GDRVTITCRASQGISSALAWYQQKPGKAP
VTITCRASQGIS
TITCRASQGISSALAWYQQKPGKAPKLLIYDASNLESG
TCRASQGISSALAWYQQKPGKAPKLL
CRASQGISSALAWYQQKPGKAPKLLIYDASNLESGV
GISSALAWYQQKPGKAPKLLIYDASNL
ISSALAWYQ
YQQKPGKAPKLLIYDASNLESGVPSRFSGSGSGTDFTLTI
KPGKAPKLLIYDASNLESGVPSRF
LLIYDASNLESGVPS
ASNLESGVPSRFSGSGSGT
LESGVPSRF
SGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQF
PSRFSGSGSGTDFTLTISSLQP
SRFSGSGSGTDFTLTISSLQPEDFATY
RFSGSGSGTDFTL
FSGSGSGTDFTLTIS
GSGSGTDFTLTISSLQPEDFATYYCQQFNSYPTFGQ
GSGSGTDFTLTISSLQPEDFATYYCQQFNSYPTFGQGTK
GTDFTLTIS
FTLTISSL
FTLTISSLQPEDFATYYCQQFN
ISSLQPEDFATYYCQQFNSYPTFGQGTKV
SSLQPEDFATYYCQQFNSYPTFGQGTKV
ATYYCQQFNSYPTFGQGTK
ATYYCQQFNSYPTFGQGTKVE
QQFNSYPTFGQG
QGTKVEIKRTVAAPSVF
QGTKVEIKRTVAAPSVFIFPPSDEQLKS
QGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASV
TKVEIKRTVAAPSVFIFPPSDEQLKSGTA
TVAAPSVFIFPPSDEQLKSGTASVVCLL
AAPSVFIFPPSDEQLKSGTASVVCLLNNF
SVFIFPP
FIFPPSDEQLKSGTASVVCLLNNF
FIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDN
QLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGN
SGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQ
VCLLNNFYPREAKVQWKVDN
VCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDS
CLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDS
FYPREAKVQWK
REAKVQWKVDNA
REAKVQWKVDNALQSGNSQESVTEQDSKDSTY
EAKVQWKVDNALQSGNSQESVTEQDSKDSTYSL
VQWKVDNALQSGNSQESV
KVDNALQSGNSQESVTEQDSKDSTYSL
VDNALQSGNSQESVTEQDSKDSTYSLSST
ALQSGNSQ
ALQSGNSQESVTEQDSKDS
ALQSGNSQESVTEQDSKDSTYS
ALQSGNSQESVTEQDSKDSTYSLSS
LQSGNSQESVTEQDSKDSTYSLSSTLTLSKA
SGNSQESVTEQDSKDSTYSLSSTLTLSKAD
QESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEV
QDSKDSTYSLSSTLT
QDSKDSTYSLSSTLTLSKADYEKHKVYACE
DSKDSTYSLSS
DSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQ
KDSTYSLSSTLTLSKADYEKHKVYACEVTH
STLTLSKADYEKHKV
STLTLSKADYEKHKVYACEVTHQGL
STLTLSKADYEKHKVYACEVTHQGLS
TLSKADYEKHKVYACEVTHQGLSSPV
KADYEKHK
EKHKVYACEVTHQGLSSPVTKS
VYACEVTHQGLSSPVT
YACEVTHQGL
YACEVTHQGLSSP
# Generated sample - 10114L|bleselumab|Homo sapiens||L-KAPPA (V-KAPPA (1-106) [D1] + C-KAPPA (107-213) [D2])|||||||213|213|||MW undefined|MW undefined| - Alfalytic protease - 50%
YYCQQFNS
FIFPPS
DEQLKS
CLLNNFYPREA
DYEKHKV
FNRGEC
# Generated sample - 9235H|tralokinumab|Homo sapiens||H-GAMMA-4 (VH (1-122) [D1] + CH1 (123-220) [D2] + CH2 (233-342) [D3] + CH3 (343-447) [D4])|||||||449|449|||MW undefined|MW undefined| - Trypsin - 50%
QVQLVQSGAEVK
KPGASVK
VTMTTDTSTSTAYMELR
SDDTAVYYCAR
GTLVTVSSASTK
GPSVFPLAPCSR
STSESTAALGCLVK
YGPPCPSCPAPEFLGGPSVFLFPPKPK
DTLMISR
EEQFNSTYR
TTPPVLDSDGSFFLYSR
SLSLSLGK
# Generated sample - 9235H|tralokinumab|Homo sapiens||H-GAMMA-4 (VH (1-122) [D1] + CH1 (123-220) [D2] + CH2 (233-342) [D3] + CH3 (343-447) [D4])|||||||449|449|||MW undefined|MW undefined| - Chymotrypsin - 50%
VQSGAEVKKPGASVKVSCKASGY
VRQAPGQGL
QGRVTM
CARDSSSSW
TSGVHTF
TCNVDHKPSNTKVDKRVESKY
GPPCPSCPAPEF
GGPSVF
PPKPKDTL
VDGVEVHNAKTKPREEQF
RVVSVL
PSDIAVEW
KTTPPVL
DSDGSF
TVDKSRW
# Generated sample - 9235H|tralokinumab|Homo sapiens||H-GAMMA-4 (VH (1-122) [D1] + CH1 (123-220) [D2] + CH2 (233-342) [D3] + CH3 (343-447) [D4])|||||||449|449|||MW undefined|MW undefined| - LysC - 50%
YGPPCPSCPAPEFLGGPSVFLFPPK
GLPSSIEK
NQVSLTCLVK
GFYPSDIAVEWESNGQPENNYK
SRWQEGNVFSCSVMHEALHNHYTQK
SLSLSLGK
# Generated sample - 9235H|tralokinumab|Homo sapiens||H-GAMMA-4 (VH (1-122) [D1] + CH1 (123-220) [D2] + CH2 (233-342) [D3] + CH3 (343-447) [D4])|||||||449|449|||MW undefined|MW undefined| - Aspecific - 50%
LVQSGAEVK
VQSGAEVKKPGASVKVSCKASGYTFTNYGLSWVRQAP
VKKPGASVKVSCKASGYTFTNYGLSWVRQAPGQG
KKPGASVKVSCKASGYTFTNYGL
KPGASVKVSCKASGYTFTNYGLSWVRQAPGQGLEWM
ASVKVSCKASGYTFTN
KASGYTFTNYGLSWVRQAPGQGLEWMG
SGYTFTNYGLSWVRQAPGQGLEWMGWISANNGDTNYG
GYTFTNYGLSWVR
FTNYGLSWVRQAPGQGLEWMGWISANNGDTNYGQEFQG
NYGLSWVRQAPGQGLEWM
NYGLSWVRQAPGQGLEWMGWISANNGDT
GQGLEWMGWISANNGDTNYGQEFQGRVTMT
LEWMGWISANNGDTNYGQEF
EWMGWISANNG
ANNGDTNYGQEFQGRVTMTTDTS
ANNGDTNYGQEFQGRVTMTTDTST
GDTNYGQEFQGRVTMTTDTSTSTAYMELRSLRSDD
GQEFQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCA
RVTMTTDTSTST
MTTDTSTSTAYMELRSLRSDDTAVY
MTTDTSTSTAYMELRSLRSDDTAVYYCARDSSSSWAR
DTSTSTAYMEL
DTSTSTAYMELRSLR
TSTSTAYMELRSLR
RSLRSDDTAVYYCARDSSSSWARWFFDLWGRGTLVT
RSDDTAVYYCARDSSSSWARWFFD
YYCARDSSSSWARWFFDL
SSSSWARW
SSSSWARWF
WFFDLWGRGTLVTVSSASTKGP
DLWGRGTLVTVSSASTKGPSVFPLAPCSRSTSE
LWGRGTLVTVSSASTKGPSVFP
GTLVTVSSASTKGPSVFPLAPCSRS
TLVTVSSASTKGP
TVSSASTKGPSVFPLAPCSRSTSESTAA
GPSVFPLAPCSRSTSEST
SVFPLAPCSRSTSESTAALGCLVK
SVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSW
PCSRSTSESTA
CSRSTSESTAALGCLVKDYFPEPV
CSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTS
RSTSESTAA
RSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVH
AALGCLV
AALGCLVKDYFPEPVTVSWNSGALTSGVHTF
AALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQS
DYFPEPVTVSWNSGAL
PEPVTVSWNSGALTSGVHTF
NSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGT
SGALTSGVHTFPAVLQSSGLYSLSSVV
GALTSGVHTFPAVL
ALTSGVHTFPAVLQ
TSGVHTFPAVLQS
FPAVLQSSGLYS
VLQSSGLYSLSS
VLQSSGLYSLSSVVTVPSSSLGT
QSSGLYSLSSVVTVPSSSLGTKTYTCN
SGLYSLSSVVTVPS
SSVVTVPSSSLGTKTYTCNV
SSLGTKTYTCN
LGTKTYTCNVDHKPSNTKVDKRVESKYGPPCPSCPAPE
GTKTYTCNVDHKPSNTKVDKRVESKYGPPCPSCPAPE
KPSNTKVDKRVESKYGPPCPSCPAPEFLGGPSV
NTKVDKRVESKYGPPCPSCPAPEFLGGPSVFLFPPKP
SKYGPPCPSCPAPEFLGGPSVFLFPP
KYGPPCPSCPAPEFLGGPSVFLFPPKPKDTLMISRTPE
PCPSCPAPEFLGGPSVFLFPP
CPAPEFLGGPSVFLFPPKPKDTLMISRTPEVTCV
PEFLGGPSVFLFPPKPKDTLMIS
GGPSVFLFPPKPKDTLMISRTP
FLFPPKPKDTLMISRTPEVTCVVVDVSQEDPEVQFNWYV
LFPPKPKDTLMI
PKPKDTLMISRTPEVTCVVVDVSQEDPE
PKPKDTLMISRTPEVTCVVVDVSQEDPEVQF
KPKDTLMISRTPEVTCVV
PKDTLMISRTPEVTCVVVDV
RTPEVTCVVVDVSQEDPEVQF
TCVVVDVSQEDPEVQFNWY
VDVSQEDPEVQFNW
VSQEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTYRVV
QEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTYRVVS
EVQFNWYVDG
VDGVEVHNAKTKPREEQFNSTYRVVSVLTVLHQD
EVHNAKTKPREEQFN
EQFNSTYRVVSVL
NSTYRVVSVLTV
TYRVVSVLTVLHQDWLN
YRVVSVLTVLHQDWLNGKEYKCKVSNKGLPS
RVVSVLTVLHQDWLNGKEYKCKVSNKGLPSSIE
VSVLTVLHQDWLNGKEYKCKVSNK
TVLHQDWLNGKEYKCKVSNKGLPSSIEKTISKAKG
LHQDWLNGKEYKCKVS
GKEYKCKVSN
KEYKCKVSNKGLP
CKVSNKGLPSSIEKTIS
KVSNKGLPSSIEKTISKAKGQPREPQ
SNKGLPSSIEKTISKAKGQPREPQVYTLPP
NKGLPSSIEKTISKAKGQPREPQVY
PSSIEKTISKAKGQPREPQVYTLPPSQEEMTKNQ
PSSIEKTISKAKGQPREPQVYTLPPSQEEMTKNQVSL
IEKTISKAK
KTISKAKGQPREPQVYTLPPSQEEMT
TISKAKG
ISKAKGQPREPQVYTLPPSQEEMTKNQVSLTCLVKGF
KAKGQPREPQVYT
REPQVYTLPPSQEEMT
EPQVYTLPPSQEE
TLPPSQEEMTKNQVSLT
LPPSQEEMTKNQVSLTCLVKGFYPSDIAVEWESNG
PPSQEEMTKNQVSLTCLVK
PSQEEMTKN
QEEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNY
QVSLTCLVKGFYPSDIAVEWESN
KGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYS
FYPSDIAVEWESNGQPENNYKTTPPVLDS
EWESNGQPENNYKTTPP
ENNYKTTPPVLDSDGSFFLYSRLTV
NNYKTTPPVLDSDGSFFLYSRLTVDKSRWQEG
KTTPPVLDSDGSFFLYSRLTVDKSRWQEGNVFSCSVM
PVLDSDGSFFLYSRLTVDKS
PVLDSDGSFFLYSRLTVDKSRWQEGNVFSCSVM
VLDSDGSFFLYSRLTVDKSRWQEGNVFSCSVMHEALH
LDSDGSFFLYSRLTVDKS
DSDGSFFLYSRLTVDKSRWQEG
DGSFFLYSRLTVDKSRWQEGNV
SFFLYSRLTVDKSRWQEGNVFSCSVMHEALHNHYTQ
SRLTVDKS
LTVDKSRWQEGNVFSCSVMHEALHNHYTQKSLS
LTVDKSRWQEGNVFSCSVMHEALHNHYTQKSLSLSLG
VDKSRWQEGNVFSCSVMHE
QEGNVFSCSVMHE
FSCSVMHEA
# Generated sample - 9235H|tralokinumab|Homo sapiens||H-GAMMA-4 (VH (1-122) [D1] + CH1 (123-220) [D2] + CH2 (233-342) [D3] + CH3 (343-447) [D4])|||||||449|449|||MW undefined|MW undefined| - Alfalytic protease - 50%
NYGQEFQGRV
YMELRS
KYGPPCPS
PEFLGGPS
QFNWYV
KPREEQFNS
LHQDWLNGKEYKCKV
NKGLPS
RWQEGNV
# Generated sample - 9235L|tralokinumab|Homo sapiens||L-LAMBDA (V-LAMBDA (1-108) [D1] + C-LAMBDA (109-214) [D2])|||||||214|214|||MW undefined|MW undefined| - Trypsin - 50%
ITCGGNIIGSK
FSGSNSGNTATLTISR
AAPSVTLFPPSSEELQANK
ATLVCLISDFYPGAVTVAWK
YAASSYLSLTPEQWK
SYSCQVTHEGSTVEK
TVAPTECS
# Generated sample - 9235L|tralokinumab|Homo sapiens||L-LAMBDA (V-LAMBDA (1-108) [D1] + C-LAMBDA (109-214) [D2])|||||||214|214|||MW undefined|MW undefined| - Chymotrypsin - 50%
QQKPGQAPVL
SGSNSGNTATL
DTGSDPVVF
GGGTKL
GQPKAAPSVTL
PPSSEEL
QANKATL
PGAVTVAW
SCQVTHEGSTVEKTVAPTECS
# Generated sample - 9235L|tralokinumab|Homo sapiens||L-LAMBDA (V-LAMBDA (1-108) [D1] + C-LAMBDA (109-214) [D2])|||||||214|214|||MW undefined|MW undefined| - LysC - 50%
SYVLTQPPSVSVAPGK
LTVLGQPK
ATLVCLISDFYPGAVTVAWK
ADSSPVK
YAASSYLSLTPEQWK
TVAPTECS
# Generated sample - 9235L|tralokinumab|Homo sapiens||L-LAMBDA (V-LAMBDA (1-108) [D1] + C-LAMBDA (109-214) [D2])|||||||214|214|||MW undefined|MW undefined| - Aspecific - 50%
VLTQPPSVSVAPGKTARITCGG
SVSVAPGKTARITCGGNIIGSKLVHWYQQKPGQAPVLV
VSVAPGKTARITCGGNIIGSKLV
VAPGKTARITCGGNIIGSKLVHWYQQKPGQAPV
KTARITCGGNIIGSKLVHWYQQKPGQAPVLVIYDD
TCGGNIIG
CGGNIIGSKLVHWYQQKPGQAPVLVIYDDGD
IIGSKLVHWYQQKPGQAPVLVI
IIGSKLVHWYQQKPGQAPVLVIYDDGDRPSGIP
GSKLVHWYQQKPGQAPVLVIYDDGDRP
GSKLVHWYQQKPGQAPVLVIYDDGDRPSGIPERFSGSNS
LVHWYQQKPGQAPVLVIYDDGDR
VLVIYDDGDRPSGIP
IYDDGDR
IYDDGDRPSG
YDDGDRPSGIPERFSGSNSGNT
DGDRPSGIPERFSGSNSGNTAT
DRPSGIPERFSGSNSGNTATLTISRVEAG
IPERFSGSNSGNTATLTISRVEAGDEADYY
GSNSGNTATLTISRV
SNSGNTATL
NSGNTATLTISR
NSGNTATLTISRVEAGDEADYYCQVWDTGSDP
SGNTATLTISRVEAGDEADYYCQVWDTG
ATLTISRVE
EADYYCQVWDTGSDPVVFGGGTKLTVLGQPKAAPSVTLF
CQVWDTGSDPV
TGSDPVVFGGGTKLTVLGQPKAAPSVTLFPP
DPVVFGGGTKLTVLGQPKAAPSVTLFPPSSEELQA
PVVFGGGTKLTVLGQPKAAPSVTLFPPSSEELQANKA
VVFGGGTKLTVLGQPKAAPSVTLFPPSSEELQA
FGGGTKLTVLGQPKAAPSVTLFPP
KLTVLGQPKAAPSVTLFPPSSEELQANKATL
LTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISD
VLGQPKAAPSVTLFPPSSEELQ
KAAPSVTLFPPSSEELQANK
AAPSVTLFPPSSEE
APSVTLFPPSSEELQAN
APSVTLFPPSSEELQANKA
APSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKAD
PSVTLFPPSSEELQANKATLVCLISDFYPGA
PSSEELQANKATLVCLISD
SEELQANKATLVCLISDFYPGAVTVAW
EELQANKATLVCLIS
KATLVCLISDFYP
KATLVCLISDFYPGAVTVAWK
TLVCLISDFYPGAVTVAWKADSSPVKAGVETTT
DFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSY
VTVAWKADSSPVKAGVETTT
TVAWKADSSPVKAGVE
PVKAGVETTTPSKQSNNKYAASSYLSLTPEQWK
PVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKS
VKAGVETTTP
VKAGVETTTPSKQSNNKYAASSYLSLT
KAGVETTTP
KAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRS
GVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYS
ETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSC
TTPSKQS
SNNKYAASSYLSLTPE
NKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTV
AASSYLSLTPEQWK
LSLTPEQWKSHRSYSCQVTHEGST
PEQWKSHRSYSCQVTHEGSTVEKTVAPTE
WKSHRSYSCQVTHEGSTVEKTVAPT
SCQVTHEGSTV
SCQVTHEGSTVEKTVAPT
THEGSTVEKTVAPTEC
# Generated sample - 9235L|tralokinumab|Homo sapiens||L-LAMBDA (V-LAMBDA (1-108) [D1] + C-LAMBDA (109-214) [D2])|||||||214|214|||MW undefined|MW undefined| - Alfalytic protease - 50%
CGGNIIGS
HWYQQKPGQA
LGQPKA
DFYPGA
PEQWKS
